_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
723853283,5/20/2015 13:50:16,1639674836,5/20/2015 13:50:02,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",treatment,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 13:51:56,1639675361,5/20/2015 13:50:57,false,neodev,1,31294288,USA,IL,Chicago,67.212.188.11,[CAUSES],[CAUSES],because the first effective drug for is no longer distributed in the United States.,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 13:52:33,1639675548,5/20/2015 13:51:09,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [CONTRAINDICATES] [LOCATION] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SYMPTOM]
[CONTRAINDICATES]
[IS_A]","11, GIARDIASIS is United States.",N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 14:12:59,1639681416,5/20/2015 14:11:19,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],effective drug for,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 14:28:51,1639686432,5/20/2015 14:28:40,false,instagc,1,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],QUINACRINE the first effective drug for GIARDIASIS,n/a,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 14:36:29,1639689036,5/20/2015 14:35:00,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],no longer distributed,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 14:39:49,1639690153,5/20/2015 14:39:33,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treat,n/a,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 14:43:04,1639691124,5/20/2015 14:40:23,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],QUINACRINE first effective drug for GIARDIASIS,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 14:57:09,1639695883,5/20/2015 14:56:46,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],effective drug for,n/a,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 15:01:08,1639697125,5/20/2015 15:00:40,false,clixsense,1,12843982,AUS,08,Perth,180.216.79.226,[TREATS],[TREATS],QUINACRINE the first effective drug for GIARDIASIS,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 15:03:42,1639698045,5/20/2015 15:02:54,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],effective drug for,n/a,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 15:03:44,1639698061,5/20/2015 15:02:02,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment no longer distributed,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 15:19:55,1639703448,5/20/2015 15:18:43,false,clixsense,1,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Metronidazole, treatment giardiasis, treat QUINACRINE effective drug GIARDIASIS",na,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 15:21:20,1639703972,5/20/2015 15:20:43,false,elite,1,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],the first effective drug for,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853283,5/20/2015 15:24:17,1639704839,5/20/2015 15:23:20,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],QUINACRINE effective drug for GIARDIASIS,N/A,192,152,-1,201,162,TWrex-cause,804291-FS1,"Metronidazole, although not approved for the treatment of giardiasis, has been the principal agent used to treat this infection  11,    64,65   because QUINACRINE the first effective drug for GIARDIASIS is no longer distributed in the United States.",GIARDIASIS,QUINACRINE
723853284,5/20/2015 12:29:44,1639650132,5/20/2015 12:29:19,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],not be administered,none,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 12:48:47,1639656945,5/20/2015 12:48:17,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DIETHYLSTILBESTROL should not be administered during PREGNANCY,n/a,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 13:09:27,1639665128,5/20/2015 13:09:09,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],administered,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 13:09:28,1639665141,5/20/2015 13:08:29,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[OTHER] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]
[OTHER]",should not be administered during,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 13:10:35,1639665359,5/20/2015 13:10:12,false,neodev,1,11382239,AUS,02,Strathfield,60.241.129.81,[CONTRAINDICATES],[CONTRAINDICATES],should not be administered,n/a,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 13:39:44,1639671004,5/20/2015 13:38:18,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [ASSOCIATED_WITH],"[LOCATION]
[ASSOCIATED_WITH]",CAUTION: be PREGNANCY,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 13:45:16,1639673365,5/20/2015 13:43:50,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],should not be administered during,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 13:45:35,1639673452,5/20/2015 13:45:23,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[OTHER],[OTHER],administered,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 13:55:28,1639676460,5/20/2015 13:54:41,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 14:12:58,1639681423,5/20/2015 14:11:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],should not be administered,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 14:18:54,1639683399,5/20/2015 14:18:28,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[NONE],[NONE],n/a,"shouldn't be g iven during pregnancy, no real relation between the two",62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 14:30:34,1639686993,5/20/2015 14:30:07,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CONTRAINDICATES],[CONTRAINDICATES],administered,n/a,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 14:38:43,1639689810,5/20/2015 14:36:47,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CONTRAINDICATES],[CONTRAINDICATES],should not be administered,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 14:44:29,1639691661,5/20/2015 14:43:26,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,[CONTRAINDICATES],[CONTRAINDICATES],DIETHYLSTILBESTROL should not be administered during PREGNANCY,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853284,5/20/2015 14:44:33,1639691694,5/20/2015 14:43:16,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[CONTRAINDICATES],[CONTRAINDICATES],should not be administered,N/A,62,9,-1,70,27,TWrex-cause,803240-FS1,CAUTION: DIETHYLSTILBESTROL should not be administered during PREGNANCY,PREGNANCY,DIETHYLSTILBESTROL
723853285,5/20/2015 10:18:44,1639608482,5/20/2015 10:18:20,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:21:50,1639609543,5/20/2015 10:21:38,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:26:19,1639611037,5/20/2015 10:25:45,false,instagc,1,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],initial treatment of,N/A,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:26:59,1639611332,5/20/2015 10:25:44,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:27:15,1639611365,5/20/2015 10:25:14,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:29:11,1639612000,5/20/2015 10:28:52,false,elite,1,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:29:15,1639612011,5/20/2015 10:28:22,false,prodege,1,15439740,AUS,02,Jannali,14.200.59.55,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],randomized trials,N/A,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:39:17,1639615413,5/20/2015 10:38:58,false,neodev,1,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]",fONDAPARINUX treatment ACUTE PROXIMAL DVT,N/A,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:41:39,1639616149,5/20/2015 10:39:49,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],fONDAPARINUX in treatment of ACUTE PROXIMAL DVT OR PE,na,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:42:54,1639616516,5/20/2015 10:42:23,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],effective,na,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:54:10,1639620094,5/20/2015 10:53:56,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 10:58:54,1639621553,5/20/2015 10:58:25,false,cointasker,1,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 11:05:12,1639623693,5/20/2015 11:04:52,false,zoombucks,1,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],fONDAPARINUX,none,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 11:14:29,1639626224,5/20/2015 11:12:08,false,clixsense,1,7074645,USA,"","",73.221.254.240,[TREATS],[TREATS],treatment,n/a,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853285,5/20/2015 11:37:33,1639632908,5/20/2015 11:36:26,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,[TREATS],[TREATS],effective treatment,Treats,145,67,-1,168,80,TWrex-cause,803482-FS1," In two randomized trials with more than 2000 patients per trial, fONDAPARINUX Was shown to be as effective and safe in the initial treatment of ACUTE PROXIMAL DVT OR PE as LMWH or UFH, respectively ( 27 ;  28.",ACUTE PROXIMAL DVT OR PE,ONDAPARINUX W
723853286,5/20/2015 08:10:58,1639570317,5/20/2015 08:10:06,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CHEMICAL ASPIRATION PNEUMONIAS resulting in entering the RESPIRATORY TRACT,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 08:12:14,1639570694,5/20/2015 08:11:34,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],occur,N,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 08:13:11,1639570949,5/20/2015 08:12:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],occur because,n/a,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 08:15:10,1639571506,5/20/2015 08:14:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[LOCATION],[LOCATION],entering the,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 08:15:32,1639571688,5/20/2015 08:15:02,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],often occur,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 08:42:21,1639579884,5/20/2015 08:42:00,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],resulting,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 08:51:04,1639582774,5/20/2015 08:49:29,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[ASSOCIATED_WITH],[ASSOCIATED_WITH],often occur,n/a,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 08:59:12,1639584931,5/20/2015 08:58:39,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],resulting in,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 09:09:04,1639587411,5/20/2015 09:08:35,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[LOCATION],[LOCATION],often occur entering the RESPIRATORY TRACT,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 09:19:55,1639590402,5/20/2015 09:19:19,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[LOCATION],[LOCATION],entering,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 09:37:21,1639595459,5/20/2015 09:36:14,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[LOCATION],[LOCATION],entering the,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 09:41:01,1639596629,5/20/2015 09:40:45,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[LOCATION],[LOCATION],entering the,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 09:47:25,1639598510,5/20/2015 09:47:02,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],"regurgitation,",N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 09:52:03,1639599876,5/20/2015 09:51:03,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],occur,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853286,5/20/2015 10:03:22,1639603413,5/20/2015 10:02:57,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[LOCATION],[LOCATION],entering the,N/A,161,0,-1,177,30,TWrex-cause,802431-FS1,"CHEMICAL ASPIRATION PNEUMONIAS often occur because of silent reflux regurgitation, resulting in acidic stomach contents and gram negative organisms entering the RESPIRATORY TRACT",RESPIRATORY TRACT,CHEMICAL ASPIRATION PNEUMONIAS
723853287,5/20/2015 12:50:59,1639657641,5/20/2015 12:50:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [LOCATION],"[TREATS]
[LOCATION]",Localized infection: EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,n/a,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 13:10:09,1639665257,5/20/2015 13:09:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treated,N/A,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 13:13:11,1639666077,5/20/2015 13:12:09,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],is treated with 1% acetic acid irrigations,N/A,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 13:14:16,1639666403,5/20/2015 13:13:46,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[OTHER],[OTHER],is treated with,n/a,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 13:42:03,1639672327,5/20/2015 13:40:50,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[SYMPTOM] [CAUSES] [LOCATION],"[CAUSES]
[LOCATION]
[SYMPTOM]",Localized EXTERNAL 1% POLYMYXIN,N/A,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 13:46:22,1639673669,5/20/2015 13:46:10,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],irrigations or topical agents,N/A,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 13:49:19,1639674497,5/20/2015 13:48:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treated,N/A,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 14:04:43,1639678798,5/20/2015 14:03:45,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],EXTERNAL OTITIS treated POLYMYXIN,N/A,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 14:21:03,1639684045,5/20/2015 14:20:38,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],EXTERNAL OTITIS is treated with POLYMYXIN B,n/a,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 14:24:31,1639685073,5/20/2015 14:24:16,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treated with,N/A,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 14:32:18,1639687616,5/20/2015 14:31:57,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treated,n/a,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 14:42:47,1639691025,5/20/2015 14:42:14,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treated,N/A,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 14:46:25,1639692337,5/20/2015 14:45:50,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER] [TREATS],"[TREATS]
[OTHER]",EXTERNAL OTITIS treated POLYMYXIN B or colistin.,na,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 14:48:42,1639693121,5/20/2015 14:48:07,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],is treated,n/a,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853287,5/20/2015 14:49:43,1639693469,5/20/2015 14:48:54,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],is treated with,n/a,22,107,-1,36,118,TWrex-cause,800892-FS1,Localized infection:  EXTERNAL OTITIS is treated with 1% acetic acid irrigations or topical agents such as POLYMYXIN B or colistin.,EXTERNAL OTITIS,POLYMYXIN B
723853288,5/20/2015 10:22:41,1639609831,5/20/2015 10:22:19,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurred,n/a,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 10:33:08,1639613278,5/20/2015 10:32:57,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurred,N/A,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 10:33:51,1639613539,5/20/2015 10:33:16,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CONTRAINDICATES],[CONTRAINDICATES],did not receive,N/A,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 10:36:55,1639614664,5/20/2015 10:36:26,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],who did not receive,N/A,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 10:43:57,1639616859,5/20/2015 10:43:32,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SIDE_EFFECT],[SIDE_EFFECT],occurred in,N/A,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 10:45:56,1639617503,5/20/2015 10:45:20,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SYMPTOM]",occurred (56%) received 16 HEPARIN.,N/A,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 10:51:15,1639619284,5/20/2015 10:50:39,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],occurred,na,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 11:01:59,1639622446,5/20/2015 11:00:25,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SIDE_EFFECT],[SIDE_EFFECT],DIC occurred in patients who received HEPARIN.,na,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 11:05:11,1639623689,5/20/2015 11:04:43,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[SIDE_EFFECT],[SIDE_EFFECT],occurred,-,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 11:10:07,1639624948,5/20/2015 11:09:47,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],DIC,none,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 12:05:57,1639641399,5/20/2015 12:05:02,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]",occurred received compared receive,n/a,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 12:11:58,1639643543,5/20/2015 12:11:44,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 12:14:31,1639644576,5/20/2015 12:14:02,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],occurred,none,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 12:26:47,1639649028,5/20/2015 12:26:05,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SIDE_EFFECT],[SIDE_EFFECT],DIC occurred in 9 of 16 patients who received heparin,N/A,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853288,5/20/2015 12:34:53,1639651949,5/20/2015 12:34:33,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],DIC,causes,0,114,-1,2,121,TWrex-cause,803246-FS1,DIC occurred in 9 of 16 (56%) patients who received heparin compared to 1 of 16 (6%) patients who did not receive HEPARIN.,DIC,HEPARIN
723853289,5/20/2015 08:16:18,1639571937,5/20/2015 08:15:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],first reason,n/a,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 08:18:37,1639572568,5/20/2015 08:17:45,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],reason,N,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 08:20:40,1639573266,5/20/2015 08:19:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],after,N/A,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 08:20:58,1639573401,5/20/2015 08:19:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,Names of people,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 08:33:59,1639577241,5/20/2015 08:33:10,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],MULLIEZ EA reason for PERSISTENT HYPERTENSION,N/A,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 08:48:07,1639581779,5/20/2015 08:47:20,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reason,N/A,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 09:05:40,1639586590,5/20/2015 09:04:40,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],n/a,no relationship specified,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 09:09:44,1639587535,5/20/2015 09:08:36,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],et al.,N/A,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 09:12:45,1639588360,5/20/2015 09:12:18,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,One term is an author the other is a condition - unrelated terms.,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 09:27:22,1639592192,5/20/2015 09:25:35,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[NONE],[NONE],N/A,MULLIEZ EA is the author of a research paper on the subject of PERSISTENT HYPERTENSION.,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 09:47:23,1639598479,5/20/2015 09:44:38,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[NONE],[NONE],n/a,mulliez is a name,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 09:49:01,1639599060,5/20/2015 09:48:32,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[NONE],[NONE],N/A,It is someone's name.,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 09:52:44,1639600118,5/20/2015 09:52:02,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],unilateral,N/A,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 10:02:48,1639603271,5/20/2015 10:02:02,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],reason for,N/A,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853289,5/20/2015 10:11:45,1639606089,5/20/2015 10:10:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,Mulliez A is a person's name I believe,127,14,-1,149,24,TWrex-cause,800496-FS1,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA
723853290,5/20/2015 13:51:31,1639675242,5/20/2015 13:51:17,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]","newer drugs,",N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 13:58:22,1639677430,5/20/2015 13:57:42,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [SIDE_EFFECT] [PART_OF],"[LOCATION]
[SIDE_EFFECT]
[PART_OF]",include absence gabapentin LAMOTRIGINE generalized,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 13:59:35,1639677772,5/20/2015 13:57:45,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",for generalized,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 14:18:53,1639683389,5/20/2015 14:17:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for generalized,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 14:40:25,1639690355,5/20/2015 14:39:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],Antiepileptic agents often include,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 14:42:37,1639690994,5/20/2015 14:42:02,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],include,n/a,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 14:50:46,1639693750,5/20/2015 14:49:24,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Antiepileptic agents include LAMOTRIGINE for SEIZURES,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 15:01:02,1639697092,5/20/2015 15:00:14,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],for generalized SEIZURES,n/a,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 15:11:51,1639700721,5/20/2015 15:09:27,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Antiepileptic agents,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 15:23:17,1639704566,5/20/2015 15:21:58,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Antiepileptic agents phenytoin carbamazepine seizures, absence and these or phenobarbital, newer drugs, LAMOTRIGINE generalized SEIZURES",na,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 15:25:48,1639705424,5/20/2015 15:24:49,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],for,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 15:28:29,1639706258,5/20/2015 15:27:41,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],LAMOTRIGINE for SEIZURES,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 15:34:05,1639707709,5/20/2015 15:33:53,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],LAMOTRIGINE for generalized SEIZURES,N/A,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 15:40:10,1639709943,5/20/2015 15:39:32,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],agents for generalized,n/a,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853290,5/20/2015 16:12:14,1639719788,5/20/2015 16:11:38,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],for,n/a,241,213,-1,248,224,TWrex-cause,800013-FS1,"Antiepileptic agents often include phenytoin or carbamazepine for partial seizures, valproic acid for absence seizures, and any of these agents or phenobarbital, with or without newer drugs, such as gabapentin or LAMOTRIGINE for generalized SEIZURES",SEIZURES,LAMOTRIGINE
723853291,5/20/2015 10:37:18,1639614813,5/20/2015 10:37:02,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],detecting,N/A,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 10:45:03,1639617188,5/20/2015 10:44:38,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],detecting,N/A,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 10:57:01,1639621009,5/20/2015 10:56:35,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[SYMPTOM] [CAUSES] [SIDE_EFFECT],"[CAUSES]
[SYMPTOM]
[SIDE_EFFECT]",Number sensitivity (95% CI) 14 71% 66% (46 86) 76%,N/A,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 11:16:09,1639626690,5/20/2015 11:15:49,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],LATENT TB*,none,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 11:21:08,1639628263,5/20/2015 11:18:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],LATENT TB* studies TUBERCULIN SKIN,na,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 12:25:46,1639648667,5/20/2015 12:24:59,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],detecting of studies testing,n/a,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 12:26:14,1639648865,5/20/2015 12:25:26,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],detecting,none,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 12:44:58,1639655438,5/20/2015 12:44:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Commercially available interferon release assays for detecting LATENT TB* Test Number of Pooled sensitivity studies TUBERCULIN SKIN testing QuantiFERON,n/a,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 12:48:57,1639656994,5/20/2015 12:48:07,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SIDE_EFFECT],[SIDE_EFFECT],detecting,na,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 13:05:16,1639663510,5/20/2015 13:04:12,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",release assays for detecting testing QuantiFERON,N/A,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 13:06:09,1639663890,5/20/2015 13:03:42,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],+,n/a,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 13:06:24,1639663974,5/20/2015 13:04:52,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],n/a,none specified,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 13:07:57,1639664514,5/20/2015 13:07:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],testing,N/A,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 13:18:41,1639667602,5/20/2015 13:17:32,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],detecting,N/A,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853291,5/20/2015 13:35:25,1639669192,5/20/2015 13:34:50,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[MANIFESTATION]",available assays Number QuantiFERON 76% (70,N/A,66,235,-1,74,250,TWrex-cause,803005-FS1,Commercially available interferon Œ≥ release assays for detecting LATENT TB*  Test                     Number of     Pooled sensitivity (95%     Number of     Pooled specificity (CI) studies       CI) +                         studies TUBERCULIN SKIN        14          71% (65 to 74)            8           66% (46 to 86) testing QuantiFERON            13          76% (70 to 83)            9.,LATENT TB,TUBERCULIN SKIN
723853292,5/20/2015 08:18:59,1639572678,5/20/2015 08:18:47,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Alternative treatment,n/a,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 08:22:20,1639573734,5/20/2015 08:22:05,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,N,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 08:25:43,1639574906,5/20/2015 08:25:26,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 08:26:30,1639575058,5/20/2015 08:25:53,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 08:40:00,1639579000,5/20/2015 08:39:29,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],NOCARDIOSIS caused by NOCARDIA,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 09:16:09,1639589340,5/20/2015 09:15:49,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 09:17:42,1639589818,5/20/2015 09:17:24,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 09:32:48,1639594129,5/20/2015 09:32:22,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 09:53:48,1639600541,5/20/2015 09:53:25,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 09:55:32,1639601012,5/20/2015 09:55:20,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],caused,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 10:05:24,1639604102,5/20/2015 10:05:08,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 10:09:36,1639605296,5/20/2015 10:08:56,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",treatment caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 10:17:29,1639608101,5/20/2015 10:17:18,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 10:20:26,1639609107,5/20/2015 10:20:07,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/a,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853292,5/20/2015 10:22:02,1639609628,5/20/2015 10:21:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,65,95,1,75,103,TWrex-cause,810975-FS1,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA
723853293,5/20/2015 10:24:49,1639610554,5/20/2015 10:24:37,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],cause,n/a,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 10:34:37,1639613794,5/20/2015 10:34:22,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],"patients,",N/A,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 10:38:59,1639615284,5/20/2015 10:37:38,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[OTHER],[OTHER],rarely causes serious complications.,Rarely causes as opposed to causes,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 10:39:23,1639615437,5/20/2015 10:39:01,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],and,N/A,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 10:50:42,1639619149,5/20/2015 10:47:53,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,The terms have nothing to do with each other.,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 10:50:49,1639619203,5/20/2015 10:50:34,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[MANIFESTATION]","cause AIDS patients, MEASLES",N/A,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 11:07:28,1639624243,5/20/2015 11:06:54,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,-,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 11:08:39,1639624505,5/20/2015 11:06:24,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA",na,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 11:12:12,1639625636,5/20/2015 11:11:50,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],INFECTION,none,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 12:17:14,1639645503,5/20/2015 12:16:39,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",occurring cause INFECTION in,n/a,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 12:18:32,1639645967,5/20/2015 12:17:36,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],cause,none,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 12:36:28,1639652501,5/20/2015 12:36:19,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],causes,N/A,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 12:38:39,1639653246,5/20/2015 12:37:57,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",n/a,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 12:43:30,1639654976,5/20/2015 12:42:49,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],can cause,na,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853293,5/20/2015 12:55:20,1639659446,5/20/2015 12:54:49,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[PREVENTS],[PREVENTS],INFECTION MEASLES MUMPS RUBELLA,n/a,91,59,1,111,68,TWrex-cause,810338-FS1,"Naturally occurring measles can cause severe, often fatal, INFECTION in AIDS patients, and MEASLES MUMPS RUBELLA rarely causes serious complications.",MEASLES MUMPS RUBELLA,INFECTION
723853294,5/20/2015 10:36:32,1639614571,5/20/2015 10:36:20,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PART_OF],[PART_OF],and,N/A,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 10:43:41,1639616771,5/20/2015 10:43:12,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",consisting of,N/A,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 10:55:00,1639620389,5/20/2015 10:53:31,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]",DISEASE caused consisting kinky RETARDATION,N/A,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 10:57:50,1639621243,5/20/2015 10:56:53,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",consisting of,N/A,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 11:14:42,1639626261,5/20/2015 11:14:22,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],"recessive gene,",none,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 11:17:19,1639627088,5/20/2015 11:16:04,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],KINKY HAIR DISEASE consisting of MENTAL RETARDATION,na,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 12:23:22,1639647786,5/20/2015 12:22:56,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 12:23:32,1639647840,5/20/2015 12:22:18,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]",caused by consisting of,n/a,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 12:42:58,1639654753,5/20/2015 12:42:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"KINKY HAIR DISEASE A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",n/a,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 12:47:23,1639656447,5/20/2015 12:46:50,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],caused,na,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 12:57:17,1639660286,5/20/2015 12:56:38,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],KINKY HAIR DISEASE consisting of MENTAL RETARDATION,na,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 13:00:26,1639661695,5/20/2015 13:00:13,false,instagc,1,23035364,USA,NJ,Voorhees,50.153.124.129,[CAUSES],[CAUSES],caused,N/A,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 13:01:50,1639662213,5/20/2015 13:00:47,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[SYMPTOM],[SYMPTOM],caused by,n/a,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 13:02:03,1639662258,5/20/2015 13:01:17,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,[SYMPTOM] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]",caused consisting of,n/a,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853294,5/20/2015 13:03:06,1639662666,5/20/2015 13:02:09,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],caused by,n/a,164,0,1,181,18,TWrex-cause,814140-FS1,"KINKY HAIR DISEASE    A congenital syndrome caused by an autosomal recessive gene, consisting of short, sparse, often poorly pigmented, kinky hair and physical and MENTAL RETARDATION",MENTAL RETARDATION,KINKY HAIR DISEASE
723853295,5/20/2015 12:55:41,1639659636,5/20/2015 12:55:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",n/a,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 13:11:44,1639665629,5/20/2015 13:11:30,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 13:42:29,1639672454,5/20/2015 13:41:35,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[OTHER],[OTHER],generally are not termed,N/A,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 13:45:57,1639673548,5/20/2015 13:45:18,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]","caused (eg,",N/A,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 13:47:50,1639674051,5/20/2015 13:47:40,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],are not termed,N/A,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 13:59:35,1639677751,5/20/2015 13:56:51,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],generally are not termed,N/A,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:24:38,1639685090,5/20/2015 14:24:24,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[NONE],[NONE],n/a,not sure what the relationship would be here,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:27:13,1639686057,5/20/2015 14:24:42,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],Liver infections caused by NONHEPATITIS VIRUSES are not termed ACUTE VIRAL HEPATITIS,N/A,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:30:30,1639686959,5/20/2015 14:29:35,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],not termed,N/A,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:35:35,1639688800,5/20/2015 14:34:54,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:52:45,1639694314,5/20/2015 14:51:04,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],are not termed,N/A,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:53:43,1639694550,5/20/2015 14:52:59,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],not termed,differs from,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:54:07,1639694664,5/20/2015 14:52:46,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[NONE],[NONE],N/A,IT  IS GENERALLY NOT TERMED AS ACUTE VIRAL HEPATITIS.,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:54:50,1639694958,5/20/2015 14:53:03,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],NA,I could find none that really fit this,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853295,5/20/2015 14:54:50,1639694962,5/20/2015 14:53:49,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],caused by,n/a,123,27,1,143,47,TWrex-cause,812481-FS1,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES
723853296,5/20/2015 10:18:18,1639608339,5/20/2015 10:18:07,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:21:35,1639609444,5/20/2015 10:21:18,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:25:13,1639610659,5/20/2015 10:23:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],mass treatment programs,n/a,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:25:40,1639610786,5/20/2015 10:25:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],reported from,N/A,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:25:44,1639610820,5/20/2015 10:24:00,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],administration mass treatment,N/A,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:28:20,1639611785,5/20/2015 10:27:53,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reported from,N/A,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:28:50,1639611937,5/20/2015 10:27:56,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,n/a,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:38:55,1639615249,5/20/2015 10:36:45,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]",encephalopathy related IVERMECTIN ONCHOCERCIASIS,N/A,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:39:48,1639615606,5/20/2015 10:38:18,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],IVERMECTIN administration from ONCHOCERCIASIS mass treatment programs,na,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:42:22,1639616451,5/20/2015 10:41:33,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,na,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:53:54,1639620040,5/20/2015 10:53:35,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],from,N/A,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 10:58:24,1639621444,5/20/2015 10:56:17,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 11:04:51,1639623608,5/20/2015 11:04:17,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],IVERMECTIN,none,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 11:12:07,1639625615,5/20/2015 11:11:20,false,clixsense,1.0,7074645,USA,"","",73.221.254.240,[TREATS],[TREATS],reported treatment,n/a,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853296,5/20/2015 11:50:38,1639636446,5/20/2015 11:48:49,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS],[TREATS],treatment,n/a,86,46,-1,99,56,TWrex-cause,805311-FS1,Loa loa  encephalopathy temporally related to IVERMECTIN administration reported from ONCHOCERCIASIS mass treatment programs from 1989 to 2001: implications for the future.,ONCHOCERCIASIS,IVERMECTIN
723853297,5/20/2015 13:50:45,1639674989,5/20/2015 13:50:31,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[OTHER],[OTHER],test to screen,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 13:54:27,1639676114,5/20/2015 13:53:17,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[PREVENTS] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [CONTRAINDICATES] [MANIFESTATION],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[CONTRAINDICATES]
[ASSOCIATED_WITH]",suppression test to screen for,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 13:55:26,1639676447,5/20/2015 13:53:28,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION],[LOCATION],CUSHING'S SYNDROME,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 14:15:14,1639682142,5/20/2015 14:14:09,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test to screen for,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 14:38:06,1639689572,5/20/2015 14:37:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screen for,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 14:40:51,1639690479,5/20/2015 14:40:33,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test,n/a,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 14:46:46,1639692449,5/20/2015 14:45:01,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 14:58:37,1639696428,5/20/2015 14:58:06,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],suppression test,n/a,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 15:07:58,1639699480,5/20/2015 15:06:28,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],suppression test,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 15:20:53,1639703823,5/20/2015 15:20:17,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],DEXAMETHASONE suppression test screen CUSHING'S SYNDROME,na,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 15:22:39,1639704412,5/20/2015 15:22:08,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test to screen for,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 15:25:26,1639705312,5/20/2015 15:24:32,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test to screen for,n/a,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 15:26:18,1639705588,5/20/2015 15:25:37,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 15:31:22,1639707004,5/20/2015 15:31:07,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853297,5/20/2015 15:36:28,1639708619,5/20/2015 15:35:14,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[SIDE_EFFECT] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]",to for,N/A,154,109,-1,171,122,TWrex-cause,803016-FS1,"2]  Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose DEXAMETHASONE suppression test to screen for CUSHING'S SYNDROME",CUSHING'S SYNDROME,DEXAMETHASONE
723853298,5/20/2015 08:19:27,1639572856,5/20/2015 08:19:00,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 08:23:19,1639574129,5/20/2015 08:22:21,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],concomitant,NA,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 08:26:21,1639575031,5/20/2015 08:25:45,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is rarely associated with,N/A,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 08:26:52,1639575184,5/20/2015 08:26:32,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 08:41:22,1639579509,5/20/2015 08:40:01,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[NONE],[NONE],none,There doesn't appear to be a significant relation between the two terms.,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 09:16:33,1639589504,5/20/2015 09:16:11,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,Two unrelated conditions,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 09:19:25,1639590253,5/20/2015 09:17:44,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER] [NONE],"[OTHER]
[NONE]",No relationship,No relationship,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 09:35:30,1639594922,5/20/2015 09:32:49,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[NONE],[NONE],N/A,There is no obvious relationship between DIABETES MELLITUS and  HEMOCHROMATOSIS in the passage.,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 09:54:31,1639600806,5/20/2015 09:53:50,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],function tests,N/A,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 09:56:12,1639601178,5/20/2015 09:55:33,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[SYMPTOM],[SYMPTOM],concomitant testosterone,N/A,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 10:06:08,1639604309,5/20/2015 10:05:26,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[ASSOCIATED_WITH],[ASSOCIATED_WITH],have concomitant,N/A,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 10:10:19,1639605521,5/20/2015 10:09:38,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is associated with,N/A,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 10:17:52,1639608247,5/20/2015 10:17:30,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 10:21:00,1639609274,5/20/2015 10:20:30,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853298,5/20/2015 10:24:59,1639610607,5/20/2015 10:22:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,I can't see a relation between the terms.,64,255,1,80,270,TWrex-cause,814940-FS1,"By contrast, only 17% of noncirrhotic patients have concomitant DIABETES MELLITUS (tvml 36tvml ) Thyroid function tests             Hypothyroidism is rarely associated with hemochromatosis (tvml 37tvml ) Total and free serum testosterone             Most HEMOCHROMATOSIS patients with hypogonadism have hypogonadotrophic hypogonadism (tvml 38tvml ) ECG = electrocardiography; HII = hepatic iron index; MRI = magnetic resonance imaging.",DIABETES MELLITUS,HEMOCHROMATOSIS
723853299,5/20/2015 12:27:00,1639649144,5/20/2015 12:26:37,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 12:27:16,1639649328,5/20/2015 12:26:53,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",used for treatment caused,n/a,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 12:46:25,1639656090,5/20/2015 12:46:01,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",Plague Has been used for treatment of PLAGUE caused by YERSINIA PESTIS,n/a,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 13:06:49,1639664092,5/20/2015 13:06:06,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",for treatment caused by,N/A,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 13:07:17,1639664230,5/20/2015 13:06:58,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],caused by,n/a,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 13:07:46,1639664434,5/20/2015 13:07:01,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[OTHER],[OTHER],caused by,n/a,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 13:08:22,1639664687,5/20/2015 13:08:12,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 13:21:11,1639668451,5/20/2015 13:19:51,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 13:36:43,1639669773,5/20/2015 13:36:02,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [LOCATION] [SYMPTOM],"[CAUSES]
[LOCATION]
[SYMPTOM]",Plague PLAGUE + caused,N/A,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 13:44:51,1639673163,5/20/2015 13:44:36,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",used,N/A,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 13:51:40,1639675290,5/20/2015 13:49:55,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],PLAGUE caused by YERSINIA PESTIS,N/A,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 14:07:31,1639679588,5/20/2015 14:05:04,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 14:08:29,1639679852,5/20/2015 14:08:20,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],caused,N/A,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 14:17:09,1639682732,5/20/2015 14:14:32,false,elite,1,31956791,USA,PA,Freeport,72.23.204.146,[CAUSES],[CAUSES],PLAGUE caused by YERSINIA PESTIS,I didn't select none,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853299,5/20/2015 14:17:35,1639682887,5/20/2015 14:17:23,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],PLAGUE caused by YERSINIA PESTIS,n/a,44,69,1,49,84,TWrex-cause,811277-FS1,118  Plague  Has been used for treatment of PLAGUE   +    caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
723853300,5/20/2015 12:28:00,1639649504,5/20/2015 12:27:00,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],"infection,",none,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 12:47:37,1639656529,5/20/2015 12:46:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"A positive reaction may indicate latent infection, prior infection, and/or M TUBERCULOSIS disease and may not indicate ACTIVE TB; c d individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",n/a,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 13:07:37,1639664337,5/20/2015 13:06:52,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[ASSOCIATED_WITH]",may not indicate,N/A,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 13:08:37,1639664792,5/20/2015 13:08:23,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],indicate,N/A,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 13:09:46,1639665184,5/20/2015 13:07:48,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may not indicate,n/a,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 13:37:15,1639669959,5/20/2015 13:36:46,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [LOCATION] [SYMPTOM],"[CAUSES]
[LOCATION]
[SYMPTOM]",144 TB; c positive guidelines,N/A,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 13:42:30,1639672456,5/20/2015 13:41:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"latent infection, prior infection, and/or",N/A,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 13:45:07,1639673274,5/20/2015 13:44:51,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],considered positive,N/A,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 13:53:42,1639675866,5/20/2015 13:51:41,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],M TUBERCULOSIS disease may not indicate ACTIVE TB;,N/A,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 14:09:56,1639680373,5/20/2015 14:07:32,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],A positive reaction,"""A positive reaction"" is the combining term, the other may be unrelated.",138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 14:18:11,1639683142,5/20/2015 14:17:36,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[SYMPTOM],[SYMPTOM],M TUBERCULOSIS may not indicate ACTIVE TB;,n/a,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 14:25:19,1639685303,5/20/2015 14:24:28,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],indicate,n/a,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 14:36:29,1639689028,5/20/2015 14:34:19,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],indicate,N/A,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 14:37:28,1639689360,5/20/2015 14:37:11,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853300,5/20/2015 14:47:58,1639692866,5/20/2015 14:45:23,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,none fit,138,93,1,146,107,TWrex-cause,811950-FS1,"b ,   c ,   144  A positive reaction may indicate latent infection, prior infection, and/or  M TUBERCULOSIS  disease and may not indicate ACTIVE TB;  c ,   d   individuals with a positive reaction should be considered positive by current public health guidelines and referred for further medical evaluation.",ACTIVE TB,M TUBERCULOSIS
723853301,5/20/2015 08:15:00,1639571433,5/20/2015 08:14:49,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 08:15:40,1639571738,5/20/2015 08:15:10,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],caused,N,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 08:17:50,1639572304,5/20/2015 08:17:25,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 08:18:18,1639572385,5/20/2015 08:17:59,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 08:30:19,1639576099,5/20/2015 08:29:26,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],LISTERIOSIS caused by LISTERIA MONOCYTOGENES,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 08:45:37,1639580975,5/20/2015 08:45:19,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],caused,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 08:58:59,1639584828,5/20/2015 08:58:17,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],caused by,none,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 09:03:59,1639586143,5/20/2015 09:03:35,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 09:11:10,1639587912,5/20/2015 09:10:58,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],caused by,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 09:23:04,1639591190,5/20/2015 09:22:44,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],caused by,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 09:42:47,1639597122,5/20/2015 09:42:11,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 09:47:26,1639598520,5/20/2015 09:45:00,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 09:49:40,1639599287,5/20/2015 09:49:19,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[MANIFESTATION],[MANIFESTATION],caused,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 09:59:33,1639602240,5/20/2015 09:58:34,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853301,5/20/2015 10:06:35,1639604423,5/20/2015 10:06:19,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,53,76,1,63,98,TWrex-cause,810469-FS1,l  Listeria Infections  Alternative for treatment of LISTERIOSIS caused by  LISTERIA MONOCYTOGENES,LISTERIOSIS,LISTERIA MONOCYTOGENES
723853302,5/20/2015 08:07:56,1639569314,5/20/2015 08:07:16,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],BLEOMYCIN treatment of SQUAMOUS CELL CARCINOMA,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 08:08:48,1639569620,5/20/2015 08:08:11,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,NA,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 08:12:00,1639570626,5/20/2015 08:11:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment of,n/a,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 08:13:03,1639570892,5/20/2015 08:12:35,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for the treatment of,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 08:13:46,1639571077,5/20/2015 08:13:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 08:40:47,1639579252,5/20/2015 08:40:30,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 08:46:39,1639581396,5/20/2015 08:45:52,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],N?A,no relationship specified,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 08:54:38,1639583663,5/20/2015 08:53:41,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 09:07:30,1639587045,5/20/2015 09:07:14,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],for the treatment of,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 09:13:45,1639588683,5/20/2015 09:13:25,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 09:34:20,1639594599,5/20/2015 09:33:29,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment of advanced,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 09:39:31,1639596216,5/20/2015 09:39:14,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],for the treatment of,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 09:45:50,1639597963,5/20/2015 09:45:27,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],treatment,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 09:48:33,1639598855,5/20/2015 09:47:47,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment,N/A,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853302,5/20/2015 10:02:41,1639603216,5/20/2015 10:01:42,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,186,76,-1,208,85,TWrex-cause,800825-FS1,"Pennacchio JL, Hong WK, Shapshay S et al. Combination of  cis  platinum and BLEOMYCIN prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced SQUAMOUS CELL CARCINOMA of the head and neck.",SQUAMOUS CELL CARCINOMA,BLEOMYCIN
723853303,5/20/2015 08:15:42,1639571739,5/20/2015 08:15:16,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],high specificity for,n/a,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 08:16:48,1639572082,5/20/2015 08:16:16,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],characteristic,N,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 08:18:59,1639572674,5/20/2015 08:18:09,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],has a moderately high specificity for,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 08:19:28,1639572850,5/20/2015 08:18:41,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],are later found to have,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 08:32:13,1639576704,5/20/2015 08:31:16,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],MYOCLONUS high for CREUTZFELDT JAKOB DISEASE,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 08:46:54,1639581506,5/20/2015 08:46:00,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[ASSOCIATED_WITH],[ASSOCIATED_WITH],has,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 09:03:57,1639586139,5/20/2015 09:01:10,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[ASSOCIATED_WITH],[ASSOCIATED_WITH],high specificity for,none,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 09:08:09,1639587212,5/20/2015 09:05:16,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],specificity,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 09:12:00,1639588154,5/20/2015 09:11:26,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,Not related in any way.,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 09:25:03,1639591640,5/20/2015 09:23:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],patients have,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 09:44:08,1639597455,5/20/2015 09:43:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],moderately high specificity for,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 09:48:12,1639598726,5/20/2015 09:47:41,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[MANIFESTATION],[MANIFESTATION],moderately high specificity for,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 09:51:10,1639599663,5/20/2015 09:49:57,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[SYMPTOM],[SYMPTOM],moderately,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 10:01:19,1639602757,5/20/2015 10:00:11,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test,N/A,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853303,5/20/2015 10:09:04,1639605057,5/20/2015 10:07:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],moderately high specificity for,n/a,174,361,1,182,386,TWrex-cause,813861-FS1,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE
723853304,5/20/2015 12:31:23,1639650737,5/20/2015 12:29:44,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SIDE_EFFECT],[SIDE_EFFECT],suboptimal responses,none,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 12:49:27,1639657156,5/20/2015 12:48:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",n/a,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 13:09:44,1639665187,5/20/2015 13:09:28,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 13:10:50,1639665439,5/20/2015 13:09:31,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Managing,N/A,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 13:12:01,1639665719,5/20/2015 13:10:36,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[NONE],[NONE],n/a,Not related - 2 different sub-headings,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 13:40:13,1639671277,5/20/2015 13:39:47,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PREVENTS] [MANIFESTATION] [ASSOCIATED_WITH],"[PREVENTS]
[MANIFESTATION]
[ASSOCIATED_WITH]",relapse Identifying suboptimal DRUG TOXICITY EFFECTS vertebral,N/A,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 13:45:52,1639673527,5/20/2015 13:45:36,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[PREVENTS],[PREVENTS],myelosuppression and vertebral compression.,N/A,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 13:46:30,1639673701,5/20/2015 13:45:18,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suboptimal responses,N/A,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 13:58:06,1639677367,5/20/2015 13:55:29,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],"Identifying and treating suboptimal responses (i.e., DRUG TOXICITY Managing MEDICATION SIDE EFFECTS",N/A,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 14:19:27,1639683611,5/20/2015 14:18:55,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],DRUG TOXICITY MEDICATION SIDE EFFECTS,n/a,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 14:22:58,1639684576,5/20/2015 14:20:52,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],treating suboptimal responses,N/A,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 14:31:38,1639687310,5/20/2015 14:30:35,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SIDE_EFFECT],[SIDE_EFFECT],SIDE EFFECTS,n/a,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 14:41:35,1639690715,5/20/2015 14:38:44,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[NONE],[NONE],N/A,Different responses,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 14:45:23,1639691917,5/20/2015 14:44:30,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,None of these fit,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853304,5/20/2015 14:45:51,1639692061,5/20/2015 14:44:40,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[PART_OF],[PART_OF],DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS,N/A,132,107,1,154,120,TWrex-cause,815128-FS1,"relapse ; Identifying and treating suboptimal responses (i.e., treatment failure, incomplete response, and DRUG TOXICITY ; Managing MEDICATION SIDE EFFECTS especially myelosuppression and vertebral compression.",MEDICATION SIDE EFFECTS,DRUG TOXICITY
723853305,5/20/2015 10:35:33,1639614117,5/20/2015 10:35:21,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 10:41:15,1639616039,5/20/2015 10:40:51,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",treatment for,N/A,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 10:51:59,1639619460,5/20/2015 10:51:40,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION] [MANIFESTATION] [SIDE_EFFECT] [SYMPTOM],"[LOCATION]
[SYMPTOM]
[MANIFESTATION]
[SIDE_EFFECT]","D, Meinking 5% treatment",N/A,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 10:52:51,1639619684,5/20/2015 10:52:16,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment for,N/A,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 11:10:10,1639624980,5/20/2015 11:09:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alPERMETHRIN treatment for SCABIES,na,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 11:13:17,1639625884,5/20/2015 11:12:57,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],alPERMETHRIN,none,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:19:48,1639646379,5/20/2015 12:19:27,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS],[TREATS],treatment for,n/a,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:20:34,1639646680,5/20/2015 12:19:53,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:40:26,1639653873,5/20/2015 12:39:50,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",n/a,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:45:02,1639655464,5/20/2015 12:44:44,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,na,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:55:21,1639659454,5/20/2015 12:55:09,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],alPERMETHRIN new treatment for SCABIES,n/a,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:57:05,1639660163,5/20/2015 12:56:34,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[TREATS],[TREATS],alPERMETHRIN 5% SCABIES,n/a,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:59:28,1639661278,5/20/2015 12:59:14,false,instagc,1.0,23035364,USA,NJ,Voorhees,50.153.124.129,[TREATS],[TREATS],treatment,N/A,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:59:35,1639661330,5/20/2015 12:59:05,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[TREATS],[TREATS],treatment for,n/a,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853305,5/20/2015 12:59:37,1639661343,5/20/2015 12:58:44,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],treatment,n/a,89,41,-1,95,51,TWrex-cause,803667-FS1,"Taplin D, Meinking TL, Porcelain SL et alPERMETHRIN 5% dermal cream: a new treatment for SCABIES",SCABIES,PERMETHRIN
723853306,5/20/2015 08:18:21,1639572398,5/20/2015 08:17:50,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],condition in which,n/a,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 08:21:38,1639573589,5/20/2015 08:21:12,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],"findings fatigue, PAIN",NA,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 08:24:23,1639574468,5/20/2015 08:23:46,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],are often significant.,N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 08:25:28,1639574835,5/20/2015 08:24:47,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",are often significant.,N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 08:38:20,1639578545,5/20/2015 08:37:40,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],FIBROSITIS PAIN often significant.,N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 09:15:22,1639589177,5/20/2015 09:14:06,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],subjective PAIN,N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 09:15:25,1639589206,5/20/2015 09:14:52,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[SYMPTOM],[SYMPTOM],subjective often significant.,N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 09:31:59,1639593842,5/20/2015 09:30:02,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[NONE],[NONE],N/A,Pain refers to fibromyalgia; it is not referred to in the context of fibrositis.,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 09:50:54,1639599630,5/20/2015 09:50:29,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],"but subjective fatigue, PAIN",N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 09:52:31,1639600079,5/20/2015 09:51:07,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],"subjective fatigue,",N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 09:54:57,1639600894,5/20/2015 09:54:38,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],PAIN,N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 10:07:41,1639604687,5/20/2015 10:06:58,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],is a condition,N/A,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 10:16:41,1639607757,5/20/2015 10:16:13,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],are often significant.,n/a,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 10:19:26,1639608724,5/20/2015 10:18:39,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],in which,n/a,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853306,5/20/2015 10:22:50,1639609857,5/20/2015 10:20:02,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM],[SYMPTOM],are often significant.,n/a,158,24,1,161,34,TWrex-cause,812657-FS1,"SYN:   fibromyositis ;  FIBROSITIS   SEE:   table  PATIENT CARE: Fibromyalgia is a condition in which objective findings are limited, but subjective fatigue, PAIN and distress are often significant.",PAIN,FIBROSITIS
723853307,5/20/2015 12:26:36,1639648982,5/20/2015 12:26:15,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 12:26:52,1639649058,5/20/2015 12:25:47,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [IS_A] [PART_OF] [TREATS] [MANIFESTATION],"[TREATS]
[CAUSES]
[MANIFESTATION]
[IS_A]
[PART_OF]",grow is in treatment caused by,n/a,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 12:46:00,1639655915,5/20/2015 12:44:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range 40 Progestins High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS,n/a,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 12:49:23,1639657137,5/20/2015 12:48:58,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,na,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 13:06:02,1639663842,5/20/2015 13:05:19,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",in the treatment of caused by,N/A,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 13:06:55,1639664113,5/20/2015 13:06:26,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],caused by,n/a,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 13:06:57,1639664118,5/20/2015 13:06:11,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[MANIFESTATION],[MANIFESTATION],caused by,n/a,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 13:08:10,1639664611,5/20/2015 13:07:58,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 13:19:50,1639668002,5/20/2015 13:18:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 13:35:58,1639669378,5/20/2015 13:35:28,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]
[SYMPTOM]",Endometriosis estradiol demonstrated multiple PELVIC ENDOMETRIOSIS,N/A,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 13:44:36,1639673073,5/20/2015 13:44:05,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH],[ASSOCIATED_WITH],grow multiple clinical trials,N/A,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 13:49:54,1639674718,5/20/2015 13:49:01,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],PELVIC PAIN caused by ENDOMETRIOSIS,N/A,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 14:05:03,1639678859,5/20/2015 14:03:35,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 14:08:19,1639679794,5/20/2015 14:08:05,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],caused,N/A,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853307,5/20/2015 14:18:01,1639683085,5/20/2015 14:17:11,false,elite,1.0,31956791,USA,PA,Freeport,72.23.204.146,[CAUSES],[CAUSES],PELVIC PAIN caused by ENDOMETRIOSIS,n/a,309,331,1,319,344,TWrex-cause,814719-FS1,Endometriosis lesions grow when serum estradiol concentration is in the premenopausal range (30 to 300 pg/mL) and regress when estradiol levels are in the menopausal range (  40  Progestins  High dose synthetic progestins have been demonstrated in multiple clinical trials to be effective in the treatment of PELVIC PAIN caused by ENDOMETRIOSIS [ see  Table 5.,PELVIC PAIN,ENDOMETRIOSIS
723853308,5/20/2015 13:51:16,1639675159,5/20/2015 13:50:58,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[PREVENTS],[PREVENTS],prevention,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 13:57:24,1639677156,5/20/2015 13:56:06,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [PREVENTS] [ASSOCIATED_WITH] [CONTRAINDICATES],"[TREATS]
[PREVENTS]
[CONTRAINDICATES]
[ASSOCIATED_WITH]",have been shown to be efficacious for,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 13:57:39,1639677241,5/20/2015 13:57:01,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [SIDE_EFFECT],"[LOCATION]
[SIDE_EFFECT]",low molecular VTE surgical patients.,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 14:17:41,1639682930,5/20/2015 14:16:23,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],prevention,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 14:39:30,1639690078,5/20/2015 14:38:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],prevention,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 14:42:01,1639690838,5/20/2015 14:41:36,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevention,n/a,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 14:49:24,1639693331,5/20/2015 14:48:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],WARFARIN for VTE prevention,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 15:00:12,1639696869,5/20/2015 14:59:56,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],prevention,n/a,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 15:09:27,1639699949,5/20/2015 15:09:02,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],prevention,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 15:21:52,1639704186,5/20/2015 15:21:33,false,clixsense,1,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],WARFARIN shown efficacious VTE prevention,na,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 15:24:48,1639705103,5/20/2015 15:24:17,false,elite,1,32732290,GBR,A7,Birmingham,80.249.56.149,[PREVENTS],[PREVENTS],efficacious for prevention,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 15:27:33,1639705994,5/20/2015 15:26:39,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],for VTE prevention,n/a,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 15:27:40,1639706024,5/20/2015 15:27:07,false,prodege,1,24403612,CAN,ON,Ajax,99.239.181.149,[PREVENTS],[PREVENTS],WARFARIN shown to be efficacious for VTE prevention,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 15:33:52,1639707637,5/20/2015 15:33:24,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],WARFARIN efficacious for VTE prevention,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853308,5/20/2015 15:40:48,1639710177,5/20/2015 15:39:33,false,neodev,1,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",to for in,N/A,132,81,-1,134,89,TWrex-cause,805296-FS1,"Low dose unfractionated heparin, low molecular weight heparin, fondaparinux, and WARFARIN have all been shown to be efficacious for VTE prevention in surgical patients.",VTE,WARFARIN
723853309,5/20/2015 13:11:55,1639665689,5/20/2015 13:11:45,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treated,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 13:43:45,1639672901,5/20/2015 13:42:32,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",for which she is being treated with,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 13:46:41,1639673750,5/20/2015 13:46:00,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [SIDE_EFFECT],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SIDE_EFFECT]
[IS_A]",significant HYPERTENSION HMG pregnant child,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 13:48:40,1639674318,5/20/2015 13:48:11,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",pregnant,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:04:46,1639678802,5/20/2015 14:03:30,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treated with,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:25:44,1639685492,5/20/2015 14:24:39,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],HYPERTENSION for which is being treated with HYDROCHLOROTHIAZIDE;,n/a,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:30:07,1639686859,5/20/2015 14:27:14,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],HYPERTENSION treated with HYDROCHLOROTHIAZIDE;,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:30:54,1639687043,5/20/2015 14:30:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treated with,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:36:04,1639688957,5/20/2015 14:35:36,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treated,n/a,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:53:07,1639694397,5/20/2015 14:52:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treated,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:54:01,1639694634,5/20/2015 14:53:44,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treated,n/a,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:54:45,1639694955,5/20/2015 14:54:10,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[TREATS],[TREATS],HYPERTENSION treated with HYDROCHLOROTHIAZIDE;,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:55:56,1639695387,5/20/2015 14:54:51,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],treated with,n/a,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 14:59:02,1639696552,5/20/2015 14:58:32,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],HYPERTENSION being treated with HYDROCHLOROTHIAZIDE;,na,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853309,5/20/2015 15:17:41,1639702759,5/20/2015 15:17:15,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],is being treated with,N/A,57,106,-1,68,125,TWrex-cause,804120-FS1,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE
723853310,5/20/2015 08:09:03,1639569687,5/20/2015 08:08:22,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],VTE events could be controlled by WARFARIN,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 08:10:52,1639570285,5/20/2015 08:09:34,false,prodege,1,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],controlled,NA,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 08:12:33,1639570753,5/20/2015 08:12:14,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],controlled,n/a,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 08:13:47,1639571084,5/20/2015 08:13:25,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],could be controlled by,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 08:14:21,1639571278,5/20/2015 08:14:05,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],could be controlled,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 08:41:27,1639579549,5/20/2015 08:41:05,false,bitcoinget,1,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],controlled,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 08:48:27,1639581930,5/20/2015 08:47:32,false,clixsense,1,21484973,GBR,L6,Shrewsbury,86.153.186.21,[TREATS],[TREATS],could be controlled by,n/a,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 08:56:03,1639584036,5/20/2015 08:55:17,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],controlled by,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 09:08:10,1639587211,5/20/2015 09:07:46,false,prodege,1,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],VTE events could be controlled by WARFARIN,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 09:14:28,1639588900,5/20/2015 09:14:05,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],controlled by,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 09:35:35,1639594969,5/20/2015 09:35:04,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],could be controlled,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 09:40:00,1639596353,5/20/2015 09:39:45,false,elite,1,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],could be controlled by,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 09:46:37,1639598192,5/20/2015 09:46:06,false,prodege,1,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],controlled,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 09:50:18,1639599510,5/20/2015 09:49:27,false,neodev,1,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],controlled by,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853310,5/20/2015 10:02:56,1639603321,5/20/2015 10:02:32,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],controlled by,N/A,78,112,-1,80,120,TWrex-cause,804760-FS1,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN
723853311,5/20/2015 12:53:53,1639658878,5/20/2015 12:53:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,n/a,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 13:11:01,1639665501,5/20/2015 13:10:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 13:19:29,1639667849,5/20/2015 13:17:36,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],can be a consideration,n/a,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 13:20:20,1639668117,5/20/2015 13:19:20,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",can be a consideration,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 13:43:55,1639672915,5/20/2015 13:43:25,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [ASSOCIATED_WITH] [CONTRAINDICATES],"[LOCATION]
[CONTRAINDICATES]
[ASSOCIATED_WITH]",involving consideration trigger CARBAMAZEPINE,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 13:47:07,1639673876,5/20/2015 13:46:55,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM] [IS_A],"[SYMPTOM]
[IS_A]",trigger zones,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 13:53:38,1639675863,5/20/2015 13:52:19,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],response to,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 14:19:11,1639683521,5/20/2015 14:18:27,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],TRIGEMINAL NEURALGIA CARBAMAZEPINE,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 14:23:49,1639684808,5/20/2015 14:22:46,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[SIDE_EFFECT],[SIDE_EFFECT],TRIGEMINAL NEURALGIA response to CARBAMAZEPINE,n/a,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 14:28:27,1639686365,5/20/2015 14:28:00,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],response to,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 14:33:44,1639688149,5/20/2015 14:33:12,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],response,n/a,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 14:48:05,1639692933,5/20/2015 14:46:24,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],response,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 14:51:41,1639694009,5/20/2015 14:50:05,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[TREATS],[TREATS],TRIGEMINAL NEURALGIA response to CARBAMAZEPINE,N/A,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 14:51:50,1639694081,5/20/2015 14:51:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],response to,n/a,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853311,5/20/2015 14:52:25,1639694205,5/20/2015 14:51:15,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],a response to,n/a,0,122,-1,19,135,TWrex-cause,805178-FS1,TRIGEMINAL NEURALGIA involving the first ophthalmic division can be a consideration where trigger zones and a response to CARBAMAZEPINE may be present.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE
723853312,5/20/2015 10:22:18,1639609729,5/20/2015 10:22:06,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],causes,n/a,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 10:32:56,1639613221,5/20/2015 10:32:05,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],causes,N/A,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 10:33:15,1639613370,5/20/2015 10:32:53,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES],[CAUSES],most common causes,N/A,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 10:36:25,1639614477,5/20/2015 10:36:06,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],causes of,N/A,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 10:43:28,1639616714,5/20/2015 10:42:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes of,N/A,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 10:45:17,1639617239,5/20/2015 10:43:24,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES] [SYMPTOM] [LOCATION],"[CAUSES]
[LOCATION]
[SYMPTOM]",DRUG INDUCED causes NEUTROPENIA,N/A,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 10:50:39,1639619142,5/20/2015 10:50:12,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],causes,na,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 11:00:23,1639622025,5/20/2015 10:57:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],DRUG INDUCED NEUTROPENIA common causes of NEUTROPENIA,na,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 11:04:42,1639623525,5/20/2015 11:04:22,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],causes,-,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 11:09:47,1639624908,5/20/2015 11:09:30,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],NEUTROPENIA,none,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 12:05:00,1639640998,5/20/2015 12:04:14,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES],[CAUSES],causes,n/a,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 12:11:38,1639643363,5/20/2015 12:11:27,false,neodev,1,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 12:14:01,1639644375,5/20/2015 12:13:08,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causes,none,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 12:26:04,1639648770,5/20/2015 12:25:36,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],DRUG INDUCED NEUTROPENIA common causes of NEUTROPENIA,N/A,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853312,5/20/2015 12:34:32,1639651866,5/20/2015 12:34:20,false,prodege,1,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],NEUTROPENIA,relations,13,0,1,23,24,TWrex-cause,811691-FS1,DRUG INDUCED NEUTROPENIA is one of the most common causes of NEUTROPENIA,NEUTROPENIA,DRUG INDUCED NEUTROPENIA
723853313,5/20/2015 12:54:19,1639659090,5/20/2015 12:53:54,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],SBE is usually caused by relatively AVIRULENT BACTERIA,n/a,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 13:11:14,1639665525,5/20/2015 13:11:02,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 13:19:49,1639667998,5/20/2015 13:19:31,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[OTHER],[OTHER],caused by,n/a,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 13:40:33,1639671635,5/20/2015 13:39:55,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[CAUSES],[CAUSES],caused by,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 13:44:31,1639673057,5/20/2015 13:43:58,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",caused (GI),N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 13:47:22,1639673956,5/20/2015 13:47:08,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],common species,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 13:55:30,1639676471,5/20/2015 13:53:40,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 14:20:03,1639683765,5/20/2015 14:19:12,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],SBE caused by AVIRULENT BACTERIA,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 14:24:01,1639684847,5/20/2015 14:23:50,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],SBE is usually caused by AVIRULENT BACTERIA,n/a,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 14:28:53,1639686446,5/20/2015 14:28:28,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 14:34:15,1639688318,5/20/2015 14:33:45,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 14:48:54,1639693198,5/20/2015 14:48:07,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 14:51:59,1639694105,5/20/2015 14:51:30,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],SBE caused by AVIRULENT BACTERIA,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 14:52:17,1639694197,5/20/2015 14:51:51,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,n/a,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853313,5/20/2015 14:52:44,1639694313,5/20/2015 14:51:44,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[CAUSES],[CAUSES],SBE usually caused by AVIRULENT BACTERIA,N/A,0,36,1,2,54,TWrex-cause,811054-FS1,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA
723853314,5/20/2015 12:51:51,1639657974,5/20/2015 12:51:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",SODIUM OXYBATE which is more commonly known as hydroxybutyrate was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration for the treatment of CATAPLEXY.,n/a,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 13:10:29,1639665325,5/20/2015 13:10:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 13:14:46,1639666578,5/20/2015 13:13:15,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",commonly known classified for the treatment,N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 13:15:05,1639666682,5/20/2015 13:14:18,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[OTHER],[OTHER],treatment of,n/a,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 13:42:44,1639672617,5/20/2015 13:42:07,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[SYMPTOM] [LOCATION] [PREVENTS] [CONTRAINDICATES],"[PREVENTS]
[LOCATION]
[SYMPTOM]
[CONTRAINDICATES]","SODIUM OXYBATE Œ≥ (GHB), CATAPLEXY.",N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 13:46:33,1639673716,5/20/2015 13:46:23,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],control,N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 13:50:52,1639675005,5/20/2015 13:49:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 14:05:49,1639679098,5/20/2015 14:04:44,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],SODIUM OXYBATE approved for treatment of CATAPLEXY.,N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 14:22:29,1639684442,5/20/2015 14:21:04,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],SODIUM OXYBATE is for the treatment of CATAPLEXY.,n/a,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 14:26:22,1639685738,5/20/2015 14:24:32,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 14:32:35,1639687704,5/20/2015 14:32:19,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 14:43:41,1639691320,5/20/2015 14:42:48,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 14:46:58,1639692500,5/20/2015 14:46:26,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],SODIUM OXYBATE hydroxybutyrate classified substance has been approved treatment of CATAPLEXY.,na,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 14:49:06,1639693266,5/20/2015 14:48:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment of,n/a,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853314,5/20/2015 14:49:43,1639693476,5/20/2015 14:49:11,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],SODIUM OXYBATE treatment of CATAPLEXY.,N/A,221,0,-1,229,14,TWrex-cause,803797-FS1,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE
723853315,5/20/2015 13:12:31,1639665900,5/20/2015 13:11:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],elevated,N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 13:44:59,1639673212,5/20/2015 13:43:50,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [SYMPTOM] [ASSOCIATED_WITH] [SIDE_EFFECT],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]","present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis,",N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 13:47:48,1639674044,5/20/2015 13:46:45,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [SIDE_EFFECT],"[LOCATION]
[SIDE_EFFECT]","Ewing leukocytosis, FEVER EWING SARCOMA",N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 13:48:57,1639674405,5/20/2015 13:48:41,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],present,N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:05:54,1639679108,5/20/2015 14:04:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],present with,N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:26:04,1639685622,5/20/2015 14:25:45,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[SYMPTOM],[SYMPTOM],Diagnosis Patients with Ewing sarcoma present FEVER and EWING SARCOMA,n/a,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:31:43,1639687320,5/20/2015 14:30:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],present with,N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:31:53,1639687363,5/20/2015 14:30:08,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","Diagnosis Patients with Ewing sarcoma present with fever, FEVER EWING SARCOMA mimics osteomyelitis.",N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:36:40,1639689091,5/20/2015 14:36:06,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],present,n/a,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:55:00,1639694995,5/20/2015 14:54:02,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],present with,n/a,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:55:19,1639695159,5/20/2015 14:53:08,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],present with,N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:55:32,1639695243,5/20/2015 14:54:48,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[SYMPTOM],[SYMPTOM],"Ewing sarcoma present with fever,",N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:56:40,1639695717,5/20/2015 14:55:57,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],With,n/a,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 14:59:18,1639696617,5/20/2015 14:59:03,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Diagnosis Patients Ewing sarcoma malaise, leukocytosis, FEVER elevated erythrocyte rate, EWING SARCOMA osteomyelitis.",na,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853315,5/20/2015 15:16:04,1639702176,5/20/2015 15:14:53,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",With,N/A,158,212,1,162,225,TWrex-cause,812664-FS1,"Diagnosis  Patients with Ewing sarcoma present with fever, weight loss, malaise, poorly localized bone pain, and a rapidly enlarging mass. With leukocytosis, FEVER and an elevated erythrocyte sedimentation rate, EWING SARCOMA mimics osteomyelitis.",FEVER,EWING SARCOMA
723853316,5/20/2015 10:22:58,1639609890,5/20/2015 10:22:43,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[LOCATION],[LOCATION],in the,n/a,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 10:33:22,1639613443,5/20/2015 10:33:10,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],patients,N/A,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 10:34:14,1639613695,5/20/2015 10:33:52,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[LOCATION],[LOCATION],in the FEET of patients with,N/A,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 10:37:21,1639614820,5/20/2015 10:36:57,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],with,N/A,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 10:44:55,1639617130,5/20/2015 10:44:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],of patients with,N/A,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 10:46:23,1639617686,5/20/2015 10:45:59,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS] [CAUSES] [PREVENTS] [ASSOCIATED_WITH],"[TREATS]
[PREVENTS]
[CAUSES]
[ASSOCIATED_WITH]",FEET with FOOT polyneuropathy.,N/A,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 10:51:47,1639619425,5/20/2015 10:51:16,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[LOCATION],[LOCATION],findings,na,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 11:03:37,1639623071,5/20/2015 11:02:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[LOCATION],[LOCATION],in the FEET of patients with BILATERAL FOOT PAIN,na,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 11:05:33,1639623770,5/20/2015 11:05:12,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Physical findings,-,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 11:10:28,1639625067,5/20/2015 11:10:08,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],fiber polyneuropathy.,none,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 12:07:28,1639641889,5/20/2015 12:05:58,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [LOCATION] [CAUSES],"[CAUSES]
[LOCATION]
[ASSOCIATED_WITH]",Physical in with from,n/a,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 12:12:12,1639643628,5/20/2015 12:12:02,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 12:15:10,1639644792,5/20/2015 12:14:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],findings,none,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 12:27:46,1639649437,5/20/2015 12:26:48,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,N/A,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853316,5/20/2015 12:35:31,1639652208,5/20/2015 12:34:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,n/a,25,47,-1,28,66,TWrex-cause,802588-FS1,Physical findings in the FEET of patients with BILATERAL FOOT PAIN from small fiber polyneuropathy.,FEET,BILATERAL FOOT PAIN
723853317,5/20/2015 10:21:45,1639609500,5/20/2015 10:21:30,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],IS,n/a,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 10:31:47,1639612826,5/20/2015 10:31:36,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],where,N/A,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 10:32:08,1639612960,5/20/2015 10:31:09,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM],[SYMPTOM],where pAIN IS frequent.,N/A,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 10:35:41,1639614197,5/20/2015 10:34:57,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[SYMPTOM],[SYMPTOM],characteristic,N/A,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 10:41:22,1639616062,5/20/2015 10:39:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],and then varying intervals,N/A,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 10:42:54,1639616515,5/20/2015 10:42:41,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]","tRIGEMINAL periods weeks, pAIN",N/A,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 10:49:25,1639618579,5/20/2015 10:48:42,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],na,typo's,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 10:55:28,1639620516,5/20/2015 10:54:46,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],tRIGEMINAL NEURALGIA intervals where pAIN IS frequent.,na,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 11:03:56,1639623183,5/20/2015 11:03:12,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[SYMPTOM],[SYMPTOM],characteristic,-,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 11:09:01,1639624606,5/20/2015 11:08:38,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],tRIGEMINAL NEURALGIA,none,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 12:02:17,1639639922,5/20/2015 12:00:49,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [ASSOCIATED_WITH] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",Rationale: characteristic pAIN,n/a,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 12:11:09,1639643223,5/20/2015 12:10:59,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 12:12:25,1639643718,5/20/2015 12:11:50,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],characteristic,none,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 12:24:23,1639648139,5/20/2015 12:22:21,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],tRIGEMINAL NEURALGIA periods which there no pain then varying intervals where pAIN IS frequent.,N/A,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853317,5/20/2015 12:34:18,1639651773,5/20/2015 12:33:59,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],tRIGEMINAL,great,170,38,1,175,59,TWrex-cause,813238-FS1,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T
723853318,5/20/2015 12:50:13,1639657367,5/20/2015 12:49:29,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Six species are now implicated in human diseases EHRLICHIA CHAFFEENSIS which causes human monocytic ehrlichiosis; Anaplasma phagocytophilum which causes human anaplasmosis; Ehrlichia ewingii which causes HUMAN EWINGII EHRLICHIOSIS; Ehrlichia canis Ehrlichia ruminantium and Neorickettsia sennetsu.,n/a,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 13:09:57,1639665225,5/20/2015 13:09:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causes,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 13:12:06,1639665736,5/20/2015 13:10:53,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[CAUSES],[CAUSES],Six species are implicated in human diseases which causes human monocytic ehrlichiosis;,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 13:13:44,1639666248,5/20/2015 13:12:02,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[NONE],[NONE],n/a,Species is not related to condition listed,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 13:40:47,1639671901,5/20/2015 13:40:16,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PREVENTS] [ASSOCIATED_WITH] [SYMPTOM] [CAUSES],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[ASSOCIATED_WITH]",]: causes EWINGII Neorickettsia sennetsu.,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 13:46:10,1639673656,5/20/2015 13:45:54,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",implicated,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 13:48:12,1639674178,5/20/2015 13:46:32,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],causes,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 14:03:43,1639678533,5/20/2015 14:02:10,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH],[ASSOCIATED_WITH],species are implicated in human diseases EHRLICHIA CHAFFEENSIS HUMAN EWINGII EHRLICHIOSIS;,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 14:20:36,1639683917,5/20/2015 14:19:28,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],EHRLICHIA CHAFFEENSIS causes HUMAN EWINGII EHRLICHIOSIS;,n/a,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 14:24:15,1639684990,5/20/2015 14:22:59,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],Six species,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 14:31:56,1639687427,5/20/2015 14:31:39,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],causes,n/a,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 14:42:13,1639690857,5/20/2015 14:41:36,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],causes,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 14:45:49,1639692055,5/20/2015 14:44:44,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],EHRLICHIA CHAFFEENSIS which causes HUMAN EWINGII EHRLICHIOSIS;,na,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 14:49:10,1639693270,5/20/2015 14:47:59,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],EHRLICHIA CHAFFEENSIS which causes HUMAN EWINGII,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853318,5/20/2015 14:50:03,1639693572,5/20/2015 14:49:03,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[CAUSES],[CAUSES],which causes which causes which causes,N/A,232,69,1,257,90,TWrex-cause,810009-FS1,"Six species are now implicated in human diseases [ see  Table 1  ]:  EHRLICHIA CHAFFEENSIS , which causes human monocytic ehrlichiosis;  Anaplasma phagocytophilum , which causes human anaplasmosis;  Ehrlichia ewingii , which causes HUMAN EWINGII EHRLICHIOSIS;  Ehrlichia canis ;  Ehrlichia ruminantium ; and  Neorickettsia sennetsu.",HUMAN EWINGII EHRLICHIOSIS,EHRLICHIA CHAFFEENSIS
723853319,5/20/2015 13:50:30,1639674921,5/20/2015 13:50:17,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",regular and comparison,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 13:53:11,1639675788,5/20/2015 13:52:13,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with bundle branch block (BBB) or antidromic,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 13:53:23,1639675829,5/20/2015 13:52:36,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION] [SYMPTOM] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SYMPTOM]
[IS_A]",tachycardia QRS is (SVT) (BBB),N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 14:14:08,1639681748,5/20/2015 14:13:01,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 14:37:30,1639689381,5/20/2015 14:36:30,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PART_OF],[PART_OF],or antidromic,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 14:40:32,1639690394,5/20/2015 14:39:50,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SIDE_EFFECT],[SIDE_EFFECT],shows,n/a,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 14:45:00,1639691799,5/20/2015 14:43:05,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],If tachycardia is regular patient may have ATRIOVENTRICULAR REENTRANT TACHYCARDIA,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 14:58:05,1639696211,5/20/2015 14:57:11,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may have with,n/a,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 15:06:27,1639699002,5/20/2015 15:03:45,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PART_OF],[PART_OF],or,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 15:11:51,1639700727,5/20/2015 15:10:02,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],with,n/a,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 15:20:17,1639703552,5/20/2015 15:19:56,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],the patient may have supraventricular TACHYCARDIA with bundle branch block antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA,na,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 15:21:59,1639704244,5/20/2015 15:21:21,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",with,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 15:25:35,1639705355,5/20/2015 15:24:19,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],TACHYCARDIA or ATRIOVENTRICULAR REENTRANT TACHYCARDIA,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 15:31:06,1639706915,5/20/2015 15:30:31,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may have supraventricular TACHYCARDIA with ATRIOVENTRICULAR REENTRANT TACHYCARDIA,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853319,5/20/2015 15:34:46,1639707955,5/20/2015 15:33:43,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]
[IS_A]",with a TACHYCARDIA (BBB) TACHYCARDIA,N/A,190,253,1,200,291,TWrex-cause,812791-FS1,"1   If the tachycardia is regular and comparison with a baseline electrocardiogram shows that the QRS complex is identical to that during sinus rhythm, the patient may have supraventricular TACHYCARDIA (SVT) with bundle branch block (BBB) or antidromic ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT.",TACHYCARDIA,ATRIOVENTRICULAR REENTRANT TACHYCARDIA
723853320,5/20/2015 08:16:52,1639572089,5/20/2015 08:16:35,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 08:19:41,1639572911,5/20/2015 08:19:10,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,NA,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 08:21:57,1639573665,5/20/2015 08:21:06,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[MANIFESTATION],[MANIFESTATION],In acute,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 08:22:19,1639573724,5/20/2015 08:21:39,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],may be present,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 08:35:39,1639577764,5/20/2015 08:34:30,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],PROMYELOCYTIC LEUKEMIA (APL) DISSEMINATED INTRAVASCULAR COAGULATION may be present on diagnosis,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 08:48:42,1639581982,5/20/2015 08:48:23,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 09:11:38,1639588032,5/20/2015 09:10:10,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM] [ASSOCIATED_WITH] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",may be present,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 09:13:35,1639588640,5/20/2015 09:13:03,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[SYMPTOM],[SYMPTOM],may be present on diagnosis,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 09:28:12,1639592440,5/20/2015 09:27:41,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[MANIFESTATION],[MANIFESTATION],may be present,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 09:49:02,1639599062,5/20/2015 09:47:54,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may be present,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 09:49:38,1639599266,5/20/2015 09:49:21,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"and some other cases of AML,",N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 09:53:36,1639600433,5/20/2015 09:53:07,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],cases,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 10:04:23,1639603791,5/20/2015 10:03:50,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 10:14:45,1639607056,5/20/2015 10:14:17,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853320,5/20/2015 10:16:31,1639607685,5/20/2015 10:15:42,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],may be present on diagnosis,n/a,67,9,1,104,37,TWrex-cause,813486-FS1,"In acute PROMYELOCYTIC LEUKEMIA (APL) and some other cases of AML, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) may be present on diagnosis and may worsen as leukemic cell lysis releases procoagulant.",DISSEMINATED INTRAVASCULAR COAGULATION,PROMYELOCYTIC LEUKEMIA (APL)
723853321,5/20/2015 13:52:20,1639675499,5/20/2015 13:52:09,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH],[ASSOCIATED_WITH],new drug,N/A,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 14:42:22,1639690918,5/20/2015 14:42:10,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],a new drug for,N/A,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 14:44:46,1639691719,5/20/2015 14:44:31,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug,n/a,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 14:56:59,1639695842,5/20/2015 14:56:07,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],VCLOZAPINE: drug for SCHIZOPHRENIA,N/A,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 15:02:59,1639697743,5/20/2015 15:02:32,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],a new drug for,n/a,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 15:17:12,1639702617,5/20/2015 15:16:53,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],new drug for,N/A,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 15:27:11,1639705811,5/20/2015 15:26:58,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],a new drug for,N/A,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 15:30:58,1639706910,5/20/2015 15:30:29,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],VCLOZAPINE: a new drug for SCHIZOPHRENIA,N/A,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 15:35:25,1639708173,5/20/2015 15:35:13,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],VCLOZAPINE: a new drug for SCHIZOPHRENIA,N/A,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 16:14:17,1639720374,5/20/2015 16:13:48,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],a new drug for,n/a,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 16:27:48,1639724541,5/20/2015 16:27:32,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",new drug,n/a,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 16:48:04,1639732747,5/20/2015 16:47:41,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],new drug for,n/a,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 16:54:23,1639735646,5/20/2015 16:54:01,false,clixsense,1,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],new drug,n/a,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 17:10:56,1639743441,5/20/2015 17:10:30,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],a new drug for,no comment,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853321,5/20/2015 17:39:26,1639758592,5/20/2015 17:38:44,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],SCHIZOPHRENIA,N/A,59,33,-1,71,42,TWrex-cause,804257-FS1,"Barrett N, Ormiston S, Molyneux VCLOZAPINE: a new drug for SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE
723853322,5/20/2015 10:35:04,1639613920,5/20/2015 10:34:39,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[IS_A],[IS_A],in,N/A,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 10:39:31,1639615487,5/20/2015 10:39:00,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],preceding enhanced HEMOLYSIS,N/A,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 10:39:55,1639615621,5/20/2015 10:39:24,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],in,N/A,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 10:51:09,1639619277,5/20/2015 10:50:54,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PREVENTS] [LOCATION] [ASSOCIATED_WITH] [CAUSES],"[PREVENTS]
[CAUSES]
[LOCATION]
[ASSOCIATED_WITH]",Korenblitt Initial HEMOLYTIC intravenous,N/A,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 10:51:37,1639619395,5/20/2015 10:50:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]",in,N/A,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 11:07:45,1639624315,5/20/2015 11:07:29,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,-,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 11:09:30,1639624799,5/20/2015 11:08:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA,na,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 11:12:37,1639625739,5/20/2015 11:12:13,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],intravenous gammaglobulin.,none,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 12:18:05,1639645776,5/20/2015 12:17:15,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",in treated with,n/a,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 12:19:27,1639646281,5/20/2015 12:18:33,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treated,none,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 12:39:11,1639653469,5/20/2015 12:38:40,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.,n/a,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 12:44:15,1639655260,5/20/2015 12:43:32,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],in,na,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 12:54:23,1639659115,5/20/2015 12:54:05,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA,n/a,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 12:56:05,1639659805,5/20/2015 12:55:21,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[PART_OF],[PART_OF],HEMOLYSIS AUTOIMMUNE HEMOLYTIC ANEMIA,n/a,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853322,5/20/2015 13:00:36,1639661780,5/20/2015 13:00:26,false,instagc,1,23035364,USA,NJ,Voorhees,50.153.124.129,[TREATS],[TREATS],treated,N/A,75,88,1,83,115,TWrex-cause,814852-FS1,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA
723853323,5/20/2015 10:36:59,1639614680,5/20/2015 10:36:47,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in,N/A,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 10:44:36,1639617030,5/20/2015 10:44:15,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],administration,N/A,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 10:56:31,1639620915,5/20/2015 10:55:47,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PREVENTS] [CONTRAINDICATES] [MANIFESTATION] [LOCATION] [SYMPTOM],"[PREVENTS]
[LOCATION]
[SYMPTOM]
[MANIFESTATION]
[CONTRAINDICATES]","National Cancer 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE AIDS activity profiles.",N/A,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 11:15:47,1639626617,5/20/2015 11:15:22,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[PREVENTS],[PREVENTS],DIDEOXYINOSINE,none,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 11:18:14,1639627364,5/20/2015 11:17:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex:,na,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 12:24:59,1639648398,5/20/2015 12:24:08,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",study administration related analysis,n/a,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 12:25:25,1639648528,5/20/2015 12:23:51,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],administration,none,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 12:44:06,1639655195,5/20/2015 12:43:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],The National Cancer Institute phase I study DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS,n/a,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 12:48:06,1639656678,5/20/2015 12:47:42,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],na,na,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 12:57:51,1639660585,5/20/2015 12:57:34,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],DIDEOXYINOSINE administration in adults wITH AIDS,n/a,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 13:03:11,1639662715,5/20/2015 13:02:27,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],administration wITH,n/a,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 13:03:40,1639662873,5/20/2015 13:03:13,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[TREATS],[TREATS],administration,n/a,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 13:04:09,1639663038,5/20/2015 13:03:28,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]",administration in adults,N/A,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 13:04:50,1639663317,5/20/2015 13:03:56,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],n/a,"just a study, doesn't specify results",138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853323,5/20/2015 13:08:55,1639664931,5/20/2015 13:08:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],administration,N/A,138,95,-1,153,111,TWrex-cause,800696-FS1,"Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute phase I study of 2‚Ä≤, 3‚Ä≤ DIDEOXYINOSINE administration in adults wITH AIDS OR AIDS related complex: analysis of activity and toxicity profiles.",ITH AIDS OR AIDS,DIDEOXYINOSINE
723853324,5/20/2015 08:17:44,1639572290,5/20/2015 08:17:30,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],outcome,n/a,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 08:21:11,1639573477,5/20/2015 08:20:54,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],Treatment,NA,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 08:23:44,1639574293,5/20/2015 08:23:26,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment outcome with,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 08:24:46,1639574599,5/20/2015 08:24:24,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Treatment outcome with,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 08:37:39,1639578371,5/20/2015 08:37:04,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],Treatment outcome CLOZAPINE TREATMENT RESISTANT PSYCHOSIS,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 09:14:05,1639588764,5/20/2015 09:13:28,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],Treatment outcome,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 09:14:51,1639589027,5/20/2015 09:14:29,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],Treatment with,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 09:30:01,1639593088,5/20/2015 09:29:41,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Treatment,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 09:50:27,1639599557,5/20/2015 09:50:15,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],Treatment outcome with,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 09:51:05,1639599657,5/20/2015 09:50:36,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Treatment outcome,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 09:54:37,1639600827,5/20/2015 09:54:26,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],Treatment,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 10:06:55,1639604518,5/20/2015 10:06:10,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],Treatment with,N/A,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 10:16:08,1639607555,5/20/2015 10:15:52,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 10:18:38,1639608431,5/20/2015 10:18:22,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],Treatment,n/a,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853324,5/20/2015 10:20:01,1639608934,5/20/2015 10:19:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Treatment outcome,n/a,126,64,-1,154,73,TWrex-cause,804018-FS1,"Small JG, Milstein V, Marhenke JD et al. Treatment outcome with CLOZAPINE in tardive dyskinesia, neuroleptic sensitivity, and TREATMENT RESISTANT PSYCHOSIS",TREATMENT RESISTANT PSYCHOSIS,CLOZAPINE
723853325,5/20/2015 10:22:05,1639609646,5/20/2015 10:21:45,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],provide relief,n/a,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 10:32:04,1639612950,5/20/2015 10:31:49,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],symptomatic,N/A,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 10:32:52,1639613197,5/20/2015 10:32:08,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],provide temporary symptomatic relief,N/A,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 10:36:05,1639614329,5/20/2015 10:35:42,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",symptomatic relief,N/A,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 10:42:20,1639616406,5/20/2015 10:41:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],provide temporary symptomatic relief,N/A,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 10:43:21,1639616691,5/20/2015 10:42:57,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES] [LOCATION] [SYMPTOM],"[CAUSES]
[LOCATION]
[SYMPTOM]",117 sales symptomatic internal HEMORRHOIDS.,N/A,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 10:50:11,1639618961,5/20/2015 10:49:25,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],symptomatic relief,na,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 10:57:36,1639621109,5/20/2015 10:55:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],PHENYLEPHRINE HYDROCHLORIDE used topically to provide relief of HEMORRHOIDS.,na,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 11:04:22,1639623380,5/20/2015 11:03:57,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[SYMPTOM],[SYMPTOM],symptomatic,-,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 11:09:29,1639624798,5/20/2015 11:09:03,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[PREVENTS],[PREVENTS],HYDROCHLORIDE,none,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 12:04:13,1639640737,5/20/2015 12:02:18,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [SYMPTOM] [LOCATION],"[TREATS]
[LOCATION]
[SYMPTOM]",preparations topically symptomatic relief external internal,n/a,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 12:11:24,1639643263,5/20/2015 12:11:13,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 12:13:07,1639643948,5/20/2015 12:12:25,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],relief,none,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 12:25:35,1639648581,5/20/2015 12:24:24,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],PHENYLEPHRINE HYDROCHLORIDE used provide temporary relief,N/A,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853325,5/20/2015 12:34:41,1639651897,5/20/2015 12:34:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],PHENYLEPHRINE HYDROCHLORIDE are used topically or rectally to provide temporary symptomatic relief of external or internal HEMORRHOIDS.,n/a,285,158,-1,295,185,TWrex-cause,804414-FS1,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE
723853326,5/20/2015 10:24:09,1639610317,5/20/2015 10:23:15,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],for,n/a,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 10:33:52,1639613543,5/20/2015 10:33:38,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PART_OF],[PART_OF],for,N/A,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 10:35:07,1639613965,5/20/2015 10:34:42,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN,N/A,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 10:38:11,1639615048,5/20/2015 10:37:53,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],for,N/A,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 10:46:46,1639617741,5/20/2015 10:46:02,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 10:49:10,1639618517,5/20/2015 10:47:38,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES] [LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]",Double BUPRENORPHINE POST,N/A,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 11:04:55,1639623621,5/20/2015 11:04:22,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN,na,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 11:06:22,1639624030,5/20/2015 11:06:00,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],blind evaluation,-,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 11:11:12,1639625345,5/20/2015 11:10:51,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BUPRENORPHINE HYDROCHLORIDE,none,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 12:09:47,1639642692,5/20/2015 12:08:53,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",evaluation of for,n/a,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 12:12:36,1639643788,5/20/2015 12:12:27,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 12:16:32,1639645265,5/20/2015 12:16:03,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],for,none,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 12:31:08,1639650627,5/20/2015 12:29:19,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,It just talks about a double blind evaluation,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 12:35:40,1639652270,5/20/2015 12:35:21,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[ASSOCIATED_WITH],[ASSOCIATED_WITH],OPERATIVE,causes,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853326,5/20/2015 12:36:18,1639652435,5/20/2015 12:35:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN,n/a,93,61,-1,111,88,TWrex-cause,800578-FS1,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE
723853327,5/20/2015 12:55:06,1639659409,5/20/2015 12:54:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN,n/a,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 13:11:30,1639665564,5/20/2015 13:11:15,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],presenting,N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 13:20:40,1639668260,5/20/2015 13:19:51,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[SYMPTOM],[SYMPTOM],after presenting,n/a,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 13:41:32,1639672210,5/20/2015 13:40:37,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [MANIFESTATION] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",were diagnosed after presenting to the emergency department,N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 13:45:15,1639673338,5/20/2015 13:44:34,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[ASSOCIATED_WITH]","ANGINA CHEST 90 days; characteristics,",N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 13:47:39,1639674011,5/20/2015 13:47:23,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]",fewer cardiac procedures,N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 13:56:50,1639676992,5/20/2015 13:55:31,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],presenting with,N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 14:21:31,1639684187,5/20/2015 14:20:04,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",diagnosed presenting to emergency department CHEST PAIN received cardiac procedures,N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 14:24:23,1639685033,5/20/2015 14:24:02,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[SYMPTOM],[SYMPTOM],UNSTABLE ANGINA after presenting with CHEST PAIN,n/a,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 14:29:34,1639686691,5/20/2015 14:28:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],presenting to,N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 14:34:53,1639688542,5/20/2015 14:34:16,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],presenting,n/a,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 14:51:03,1639693844,5/20/2015 14:48:54,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],presenting,N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 14:52:58,1639694367,5/20/2015 14:52:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],presenting with,n/a,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 14:53:01,1639694371,5/20/2015 14:52:00,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SYMPTOM],[SYMPTOM],UNSTABLE ANGINA with CHEST PAIN,N/A,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853327,5/20/2015 14:53:48,1639694583,5/20/2015 14:52:27,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],after presenting,n/a,136,70,1,145,85,TWrex-cause,812836-FS1,"CONCLUSION  Among patients who were diagnosed for the first time with UNSTABLE ANGINA after presenting to the emergency department with CHEST PAIN women received fewer cardiac procedures than did men within 90 days; after adjustment for baseline characteristics, men experienced worse outcomes during follow up.",CHEST PAIN,UNSTABLE ANGINA
723853328,5/20/2015 10:35:19,1639614037,5/20/2015 10:35:07,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 10:40:01,1639615631,5/20/2015 10:39:32,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],first line treatment of,N/A,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 10:40:50,1639615943,5/20/2015 10:39:57,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],first line treatment,N/A,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 10:51:36,1639619374,5/20/2015 10:51:12,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PREVENTS] [SYMPTOM],"[PREVENTS]
[SYMPTOM]","Raphael GD, PROPIONATE ASTHMA:",N/A,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 10:52:12,1639619532,5/20/2015 10:51:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 11:09:48,1639624907,5/20/2015 11:09:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],FLUTICASONE PROPIONATE treatment of ASTHMA:,na,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 11:12:55,1639625810,5/20/2015 11:12:39,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],FLUTICASONE PROPIONATE,none,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 12:19:26,1639646273,5/20/2015 12:18:05,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [CONTRAINDICATES],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]
[ASSOCIATED_WITH]",compared with treatment of randomized clinical trial.,n/a,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 12:19:52,1639646398,5/20/2015 12:19:27,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 12:39:49,1639653645,5/20/2015 12:39:13,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.,n/a,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 12:44:42,1639655397,5/20/2015 12:44:16,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,na,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 12:54:41,1639659278,5/20/2015 12:54:25,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Low dose FLUTICASONE PROPIONATE for treatment of persistent ASTHMA:,n/a,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 12:56:32,1639660020,5/20/2015 12:56:07,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[TREATS],[TREATS],FLUTICASONE PROPIONATE ASTHMA:,n/a,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 12:59:03,1639661070,5/20/2015 12:57:30,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[TREATS],[TREATS],treatment of,n/a,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853328,5/20/2015 12:59:13,1639661160,5/20/2015 12:58:32,false,instagc,1.0,23035364,USA,NJ,Voorhees,50.153.124.129,[TREATS],[TREATS],treatment,N/A,135,47,-1,140,69,TWrex-cause,803609-FS1,"Busse W, Raphael GD, Galant S, et al: Low dose FLUTICASONE PROPIONATE compared with montelukast for first line treatment of persistent ASTHMA: a randomized clinical trial.",ASTHMA,FLUTICASONE PROPIONATE
723853329,5/20/2015 13:50:58,1639675036,5/20/2015 13:50:46,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[PREVENTS],[PREVENTS],older patients,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 13:56:01,1639676683,5/20/2015 13:55:00,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [PART_OF] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[IS_A]
[PART_OF]","coronary heart disease (CHD) risk factor, is amlodipine",N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 13:56:58,1639677022,5/20/2015 13:55:31,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]",ÔøΩÔøΩ (CHD) CHD events.,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 14:16:22,1639682517,5/20/2015 14:15:15,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],better than chlorthalidone in lowering,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 14:38:55,1639689867,5/20/2015 14:38:07,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],lowering the risk,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 14:41:35,1639690714,5/20/2015 14:40:51,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],lowering the risk,n/a,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 14:48:09,1639692967,5/20/2015 14:46:47,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],HYPERTENSION LISINOPril lowering the risk for,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 14:59:55,1639696816,5/20/2015 14:58:38,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],lowering the risk,n/a,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 15:09:01,1639699829,5/20/2015 15:07:59,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],lowering the risk,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 15:21:31,1639704052,5/20/2015 15:20:54,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],HYPERTENSION amlodipine LISINOPril chlorthalidone the CHD cardiovascular disease events.,na,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 15:24:13,1639704837,5/20/2015 15:23:14,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[PREVENTS],[PREVENTS],in lowering the risk for CHD,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 15:26:38,1639705696,5/20/2015 15:25:27,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],better in lowering the risk,n/a,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 15:27:06,1639705801,5/20/2015 15:26:19,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],HYPERTENSION OR LISINOPril better in lowering risk,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 15:33:23,1639707517,5/20/2015 15:31:23,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],HYPERTENSION is amlodipine OR LISINOPril better lowering the risk,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853329,5/20/2015 15:39:01,1639709540,5/20/2015 15:36:32,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",In is OR in,N/A,37,125,-1,48,135,TWrex-cause,805191-FS1,"In predominately older patients with HYPERTENSION and ÔøΩÔøΩ 1 other coronary heart disease (CHD) risk factor, is amlodipine OR LISINOPril better than chlorthalidone in lowering the risk for CHD or other cardiovascular disease (CVD) events.",HYPERTENSION,OR LISINOP
723853330,5/20/2015 08:06:37,1639568865,5/20/2015 08:05:54,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],Reduces duration of nEUTROPENIA patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 08:07:28,1639569134,5/20/2015 08:06:48,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],INDUCED,NA,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 08:10:43,1639570206,5/20/2015 08:10:13,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],In patients with,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 08:11:18,1639570458,5/20/2015 08:11:04,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Reduces duration,n/a,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 08:12:51,1639570831,5/20/2015 08:12:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],with,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 08:40:01,1639579021,5/20/2015 08:39:36,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],In,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 08:45:02,1639580776,5/20/2015 08:43:50,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],N/A,No relationship,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 08:52:52,1639583232,5/20/2015 08:52:18,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],cHEMOTHERAPY INDUCED NEUTROPENIA..,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 09:06:55,1639586874,5/20/2015 09:06:30,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[IS_A],[IS_A],nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 09:12:59,1639588433,5/20/2015 09:12:25,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[IS_A],[IS_A],with,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 09:32:54,1639594189,5/20/2015 09:32:11,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],patients with,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 09:38:58,1639596067,5/20/2015 09:38:44,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[ASSOCIATED_WITH],[ASSOCIATED_WITH],In patients with,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 09:44:50,1639597632,5/20/2015 09:44:18,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[SYMPTOM],[SYMPTOM],INDUCED,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 09:46:27,1639598146,5/20/2015 09:45:10,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],Reduces,N/A,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853330,5/20/2015 10:01:41,1639602887,5/20/2015 10:00:30,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],cHEMOTHERAPY INDUCED NEUTROPENIA..,n/a,38,67,1,49,98,TWrex-cause,814342-FS1,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA
723853331,5/20/2015 08:07:14,1639569079,5/20/2015 08:06:38,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],JNICARDIPINE in the treatment of HYPERTENSION,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 08:08:10,1639569437,5/20/2015 08:07:29,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,NA,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 08:11:37,1639570529,5/20/2015 08:11:19,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 08:12:05,1639570642,5/20/2015 08:10:46,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in the treatment of,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 08:13:26,1639571036,5/20/2015 08:12:52,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 08:40:29,1639579186,5/20/2015 08:40:03,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 08:45:50,1639581057,5/20/2015 08:45:04,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],N/A,no relationship specified,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 08:53:40,1639583431,5/20/2015 08:52:54,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 09:07:13,1639586983,5/20/2015 09:06:56,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],in the treatment of,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 09:13:24,1639588554,5/20/2015 09:13:01,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 09:33:26,1639594348,5/20/2015 09:32:56,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],in the treatment,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 09:39:13,1639596118,5/20/2015 09:38:59,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],in the treatment of HYPERTENSION,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 09:45:25,1639597775,5/20/2015 09:44:51,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",treatment,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 09:47:44,1639598587,5/20/2015 09:46:29,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853331,5/20/2015 10:02:10,1639603092,5/20/2015 10:01:10,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],in the treatment of,N/A,95,45,-1,106,56,TWrex-cause,803696-FS1,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE
723853332,5/20/2015 08:04:56,1639568223,5/20/2015 08:04:18,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],VIRAL INFECTIONS that may cause EPSTEIN BARR VIRUS,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 08:06:23,1639568809,5/20/2015 08:05:59,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],cause,NA,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 08:09:36,1639569869,5/20/2015 08:09:09,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],that may cause,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 08:10:41,1639570202,5/20/2015 08:10:24,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],may cause,n/a,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 08:12:11,1639570674,5/20/2015 08:11:57,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Treat,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 08:38:45,1639578696,5/20/2015 08:38:23,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],cause,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 08:42:10,1639579831,5/20/2015 08:41:25,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],may cause,n/a,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 08:50:38,1639582631,5/20/2015 08:50:18,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],may cause,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 09:06:00,1639586666,5/20/2015 09:05:22,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],that may cause,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 09:11:51,1639588097,5/20/2015 09:11:26,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],cause,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 09:31:32,1639593660,5/20/2015 09:30:56,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],may cause,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 09:38:24,1639595881,5/20/2015 09:38:06,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],that may cause,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 09:43:55,1639597384,5/20/2015 09:43:29,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],Treat,N/A,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 09:43:59,1639597394,5/20/2015 09:43:00,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],may cause,didn't select none,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853332,5/20/2015 10:00:29,1639602483,5/20/2015 10:00:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],that may cause,n/a,18,126,1,33,144,TWrex-cause,810263-FS1,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS
723853333,5/20/2015 13:51:43,1639675294,5/20/2015 13:51:32,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",common,N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 13:58:54,1639677661,5/20/2015 13:58:25,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [LOCATION] [SYMPTOM],"[LOCATION]
[SYMPTOM]
[IS_A]",is 15 35 CLASSICAL,N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 14:04:11,1639678651,5/20/2015 14:03:27,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[ASSOCIATED_WITH]","is common at presentation,",N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 14:20:08,1639683785,5/20/2015 14:18:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],"presentation,",N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 14:40:42,1639690459,5/20/2015 14:40:26,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],"at presentation,",N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 14:43:09,1639691161,5/20/2015 14:42:38,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],"presentation,",n/a,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 14:52:10,1639694187,5/20/2015 14:50:46,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],MEDIASTINAL LYMPHADENOPATHY is common with CLASSICAL NODULAR SCLEROSIS,N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 15:01:25,1639697232,5/20/2015 15:01:03,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],"common at presentation,",n/a,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 15:13:05,1639701173,5/20/2015 15:11:52,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],"presentation,",N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 15:24:07,1639704829,5/20/2015 15:23:23,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"MEDIASTINAL LYMPHADENOPATHY common presentation, CLASSICAL NODULAR",na,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 15:26:10,1639705553,5/20/2015 15:25:50,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",in patients with,N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 15:29:20,1639706459,5/20/2015 15:28:30,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],MEDIASTINAL LYMPHADENOPATHY is common in patients with CLASSICAL NODULAR SCLEROSIS,N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 15:34:33,1639707876,5/20/2015 15:34:06,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MEDIASTINAL LYMPHADENOPATHY is common especially in patients with CLASSICAL NODULAR SCLEROSIS,N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 15:43:01,1639710839,5/20/2015 15:40:58,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],is in,N/A,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853333,5/20/2015 16:12:38,1639719878,5/20/2015 16:12:15,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],"common at presentation,",n/a,0,105,1,26,132,TWrex-cause,813772-FS1,"MEDIASTINAL LYMPHADENOPATHY is common at presentation, especially in patients 15 to 35 years of age with CLASSICAL NODULAR SCLEROSIS",MEDIASTINAL LYMPHADENOPATHY,CLASSICAL NODULAR SCLEROSIS
723853334,5/20/2015 12:29:13,1639649952,5/20/2015 12:28:02,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 12:48:16,1639656741,5/20/2015 12:47:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Treatment DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA,n/a,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 13:08:25,1639664710,5/20/2015 13:07:39,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],the only available medical treatment for,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 13:09:07,1639664986,5/20/2015 13:08:56,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 13:10:10,1639665263,5/20/2015 13:09:48,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[TREATS],[TREATS],only available medical treatment,n/a,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 13:38:15,1639670449,5/20/2015 13:37:19,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [PREVENTS],"[PREVENTS]
[LOCATION]",DANTROLENE only current dysfunction.,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 13:43:49,1639672910,5/20/2015 13:42:31,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 13:45:23,1639673373,5/20/2015 13:45:07,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],supportive therapy,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 13:54:40,1639676171,5/20/2015 13:53:42,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],DANTROLENE SODIUM only available treatment for MALIGNANT HYPERTHERMIA,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 14:11:51,1639680993,5/20/2015 14:09:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment for,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 14:18:27,1639683197,5/20/2015 14:18:12,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],DANTROLENE SODIUM treatment for MALIGNANT HYPERTHERMIA,n/a,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 14:25:42,1639685449,5/20/2015 14:25:21,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 14:36:47,1639689138,5/20/2015 14:36:31,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 14:37:39,1639689449,5/20/2015 14:37:29,false,neodev,1,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853334,5/20/2015 14:43:25,1639691233,5/20/2015 14:42:49,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],DANTROLENE SODIUM available medical treatment for MALIGNANT HYPERTHERMIA,N/A,73,14,-1,94,31,TWrex-cause,800100-FS1,"Treatment     DANTROLENE SODIUM the only available medical treatment for MALIGNANT HYPERTHERMIA    The current treatment of choice is the intravenous administration of dantrolene, the only known antidote, discontinuation of triggering agents, and supportive therapy directed at correcting hyperthermia, acidosis, and organ dysfunction.",MALIGNANT HYPERTHERMIA,DANTROLENE SODIUM
723853335,5/20/2015 13:51:55,1639675330,5/20/2015 13:51:44,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH],[ASSOCIATED_WITH],therapy,N/A,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 14:03:32,1639678399,5/20/2015 14:02:33,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [LOCATION] [CONTRAINDICATES] [SIDE_EFFECT] [PART_OF],"[CAUSES]
[LOCATION]
[CONTRAINDICATES]
[SIDE_EFFECT]
[PART_OF]",of chemotherapy ('4+2' to,N/A,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 14:21:32,1639684195,5/20/2015 14:20:09,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy for,N/A,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 14:41:37,1639690736,5/20/2015 14:40:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,"There is an error, it should be asking for APL not ""PL I"".",53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 14:44:11,1639691573,5/20/2015 14:43:10,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],therapy,n/a,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 14:54:19,1639694777,5/20/2015 14:52:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Include all tRANS RETINOIC ACID In therapy for APL In induction,N/A,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 15:01:54,1639697411,5/20/2015 15:01:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,n/a,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 15:14:06,1639701479,5/20/2015 15:13:06,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],therapy,N/A,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 15:24:39,1639705044,5/20/2015 15:24:09,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],tRANS RETINOIC ACID therapy APL,na,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 15:26:27,1639705659,5/20/2015 15:26:12,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],In the therapy for,N/A,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 15:29:54,1639706658,5/20/2015 15:29:21,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],tRANS RETINOIC ACID In therapy for APL,N/A,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 15:34:53,1639708001,5/20/2015 15:34:34,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],tRANS RETINOIC ACID In therapy for APL,N/A,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 16:13:18,1639720056,5/20/2015 16:12:40,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],In the therapy,n/a,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 16:27:12,1639724320,5/20/2015 16:25:08,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[PREVENTS],[PREVENTS],therapy,n/a,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853335,5/20/2015 16:47:40,1639732580,5/20/2015 16:46:54,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[NONE],[NONE],n/a,PL1 not mentioned at all,53,14,-1,56,34,TWrex-cause,803576-FS1, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I
723853336,5/20/2015 10:20:31,1639609141,5/20/2015 10:20:18,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:23:53,1639610257,5/20/2015 10:23:45,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:29:38,1639612129,5/20/2015 10:29:07,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],effective for treatment of,N/A,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:30:54,1639612574,5/20/2015 10:30:42,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:32:53,1639613210,5/20/2015 10:32:28,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],for treatment,N/A,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:33:43,1639613517,5/20/2015 10:33:20,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],more effective for treatment of,n/a,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:36:14,1639614403,5/20/2015 10:35:52,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:41:32,1639616110,5/20/2015 10:40:57,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION] [PREVENTS],"[PREVENTS]
[LOCATION]",cYCLOPHOSPHAMIDE PROLIFERATIVE intravenous,N/A,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:47:04,1639617884,5/20/2015 10:46:39,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,na,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 10:50:02,1639618936,5/20/2015 10:48:19,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],cYCLOPHOSPHAMIDE more effective for treatment of PROLIFERATIVE SLE NEPHRITIS,na,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 11:01:37,1639622345,5/20/2015 11:01:20,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 11:07:36,1639624274,5/20/2015 11:07:16,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],cYCLOPHOSPHAMIDE,none,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 11:54:38,1639637394,5/20/2015 11:54:21,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 11:56:49,1639638040,5/20/2015 11:55:26,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS],[TREATS],treatment,n/a,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853336,5/20/2015 12:10:10,1639642812,5/20/2015 12:09:56,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,118,66,-1,146,83,TWrex-cause,800465-FS1,"Evidence:  In a randomized controlled trial, monthly intravenous cYCLOPHOSPHAMIDE Was more effective for treatment of PROLIFERATIVE SLE NEPHRITIS Than monthly intravenous glucocorticoid therapy; combination therapy may be superior ( 52.",PROLIFERATIVE SLE NEPHRITIS T,YCLOPHOSPHAMIDE W
723853337,5/20/2015 13:13:29,1639666204,5/20/2015 13:13:13,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 13:49:44,1639674646,5/20/2015 13:49:28,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",eliminate,N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 13:49:39,1639674697,5/20/2015 13:47:34,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]","should not be started at this time,",N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 13:50:23,1639674886,5/20/2015 13:49:34,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [LOCATION],"[CAUSES]
[LOCATION]","ARRHYTHMIA ANTIARRHYTHMIC time, because perfusing focus",N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 14:09:35,1639680223,5/20/2015 14:08:22,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],should not be started,N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 14:28:10,1639686299,5/20/2015 14:27:57,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],ARRHYTHMIA ANTIARRHYTHMIC MEDICATION,n/a,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 14:33:18,1639687950,5/20/2015 14:32:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],should not be started,N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 14:37:25,1639689334,5/20/2015 14:36:16,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],ARRHYTHMIA ANTIARRHYTHMIC MEDICATION,N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 14:39:12,1639689992,5/20/2015 14:38:06,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],should not be started,n/a,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 14:56:23,1639695613,5/20/2015 14:55:54,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],should not be started,n/a,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 14:59:15,1639696584,5/20/2015 14:57:16,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[CONTRAINDICATES],[CONTRAINDICATES],"If postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, ANTIARRHYTHMIC MEDICATION should not be started",N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 15:00:24,1639696928,5/20/2015 15:00:09,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],ARRHYTHMIA idioventricular rhythm degree heart accompanied an idioventricular escape ANTIARRHYTHMIC MEDICATION not antiarrhythmic could eliminate ventricular perfusing,na,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 15:00:57,1639697077,5/20/2015 14:58:29,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],MEDICATION,n/a,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 15:00:57,1639697080,5/20/2015 14:59:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CONTRAINDICATES],[CONTRAINDICATES],should not be started,N/A,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853337,5/20/2015 15:20:21,1639703595,5/20/2015 15:18:10,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,They are negatively related but there's no way to express relation in this context.,28,148,-1,37,173,TWrex-cause,804667-FS1,"If the perfusing postarrest ARRHYTHMIA is an idioventricular rhythm or third degree heart block accompanied by an idioventricular escape rhythm, an ANTIARRHYTHMIC MEDICATION should not be started at this time, because the antiarrhythmic agent could eliminate the ventricular perfusing focus and return the patient to a pulseless state.",ARRHYTHMIA,ANTIARRHYTHMIC MEDICATION
723853338,5/20/2015 10:21:06,1639609283,5/20/2015 10:20:44,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],symptoms,n/a,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 10:30:31,1639612439,5/20/2015 10:30:09,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM],[SYMPTOM],classic symptoms,N/A,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 10:31:22,1639612729,5/20/2015 10:31:11,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],symptoms,N/A,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 10:34:15,1639613705,5/20/2015 10:33:41,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[CONTRAINDICATES],[CONTRAINDICATES],who do not manifest,N/A,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 10:36:05,1639614322,5/20/2015 10:35:05,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],manifest the classic symptoms,n/a,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 10:37:43,1639614931,5/20/2015 10:36:47,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],symptoms of,N/A,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 10:42:11,1639616343,5/20/2015 10:41:54,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES] [SYMPTOM] [LOCATION],"[CAUSES]
[LOCATION]
[SYMPTOM]",patients today CELIACS symptoms steatorrhea,N/A,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 10:48:21,1639618287,5/20/2015 10:47:34,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],symptoms,na,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 10:53:29,1639619888,5/20/2015 10:52:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],CELIACS symptoms of WEIGHT LOSS,na,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 11:02:28,1639622662,5/20/2015 11:01:59,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],identified,-,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 11:08:07,1639624427,5/20/2015 11:07:51,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],CELIACS,none,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 11:59:07,1639638948,5/20/2015 11:58:12,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",manifest symptoms,n/a,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 12:10:38,1639643044,5/20/2015 12:10:29,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 12:11:16,1639643258,5/20/2015 12:10:42,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],symptoms,none,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853338,5/20/2015 12:20:57,1639646860,5/20/2015 12:18:43,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",CELIACS manifest classic symptoms,N/A,111,43,1,121,50,TWrex-cause,813139-FS1,15   Many patients today are identified as CELIACS who do not manifest the classic symptoms of steatorrhea and WEIGHT LOSS,WEIGHT LOSS,CELIACS
723853339,5/20/2015 08:19:41,1639572910,5/20/2015 08:19:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],as treatment,n/a,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 08:24:02,1639574367,5/20/2015 08:23:20,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,N,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 08:26:44,1639575098,5/20/2015 08:26:23,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],as treatment for,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 08:27:17,1639575240,5/20/2015 08:26:53,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 08:42:01,1639579763,5/20/2015 08:41:23,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CEFTRIAXONE as treatment for uncomplicated GONORRHEA,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 09:16:46,1639589597,5/20/2015 09:16:34,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],as treatment for,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 09:19:53,1639590388,5/20/2015 09:19:27,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],as treatment for,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 09:35:50,1639595055,5/20/2015 09:35:32,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 09:54:58,1639600895,5/20/2015 09:54:33,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment for,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 09:56:34,1639601273,5/20/2015 09:56:14,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],treatment,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 10:06:25,1639604364,5/20/2015 10:06:09,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],as treatment for,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 10:10:58,1639605792,5/20/2015 10:10:23,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],as treatment for,N/A,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 10:18:06,1639608279,5/20/2015 10:17:53,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 10:21:15,1639609366,5/20/2015 10:21:02,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853339,5/20/2015 10:23:16,1639609993,5/20/2015 10:22:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment for,n/a,145,102,-1,153,113,TWrex-cause,800504-FS1,"Comment on Handsfield HH, McCormack WM, Hook EW III, et al. A comparison of single dose cefixime with CEFTRIAXONE as treatment for uncomplicated GONORRHEA",GONORRHEA,CEFTRIAXONE
723853340,5/20/2015 10:24:36,1639610485,5/20/2015 10:24:25,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatments,n/a,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 10:34:20,1639613716,5/20/2015 10:34:06,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],tetracaine,N/A,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 10:37:38,1639614899,5/20/2015 10:37:03,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],can also relieve itching and PAIN[45][46][47],N/A,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 10:39:00,1639615296,5/20/2015 10:38:35,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",can relieve,N/A,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 10:47:50,1639618126,5/20/2015 10:47:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],relieve,N/A,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 10:50:31,1639619103,5/20/2015 10:50:13,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]",LIDOCAINE several aciclovir,N/A,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 11:06:22,1639624029,5/20/2015 11:05:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],LIDOCAINE can relieve PAIN[45][46][47],na,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 11:06:53,1639624108,5/20/2015 11:06:38,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],relieve,-,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 11:11:49,1639625497,5/20/2015 11:11:31,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],LIDOCAINE,none,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 12:12:31,1639643774,5/20/2015 12:10:44,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[SYMPTOM]
[ASSOCIATED_WITH]",treatments relieve itching for treating,n/a,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 12:17:36,1639645595,5/20/2015 12:17:07,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],relieve,none,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 12:36:18,1639652434,5/20/2015 12:36:06,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[PREVENTS],[PREVENTS],relieve,N/A,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 12:37:56,1639652943,5/20/2015 12:37:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47],n/a,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 12:42:47,1639654696,5/20/2015 12:42:34,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],relieve,na,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853340,5/20/2015 12:55:08,1639659414,5/20/2015 12:54:42,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],LIDOCAINE benzocaine can relieve itching and PAIN[45][46][47],n/a,114,50,-1,117,59,TWrex-cause,800746-FS1,"Topical anesthetic treatments such as prilocaine, LIDOCAINE benzocaine or tetracaine can also relieve itching and PAIN[45][46][47] Antiviral     The antiviral medication acyclovir    There are several antivirals that are effective for treating herpes including: aciclovir (acyclovir), valaciclovir (valacyclovir), famciclovir, and penciclovir.",PAIN,LIDOCAINE
723853341,5/20/2015 08:17:29,1639572244,5/20/2015 08:17:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],probability In patients with,n/a,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 08:20:53,1639573342,5/20/2015 08:20:04,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],probability,NA,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 08:23:24,1639574178,5/20/2015 08:22:53,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],pretest probability is,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 08:24:21,1639574452,5/20/2015 08:23:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Evidence:,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 08:37:02,1639578094,5/20/2015 08:36:21,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],pretest probability ~0.5% PHEOCHROMOCYTOMA patients HYPERTENSION,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 09:13:27,1639588563,5/20/2015 09:12:28,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],estimated probability,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 09:14:28,1639588899,5/20/2015 09:13:56,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[ASSOCIATED_WITH],[ASSOCIATED_WITH],In patients with,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 09:29:39,1639592892,5/20/2015 09:28:37,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER] [SYMPTOM],"[SYMPTOM]
[OTHER]",probability ~0.5%,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 09:50:14,1639599469,5/20/2015 09:49:55,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],The estimated pretest probability,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 09:50:34,1639599580,5/20/2015 09:49:39,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],probability,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 09:54:24,1639600789,5/20/2015 09:53:59,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],estimated,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 10:06:08,1639604307,5/20/2015 10:05:27,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],pretest,N/A,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 10:15:51,1639607441,5/20/2015 10:15:16,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],In with,n/a,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 10:18:21,1639608385,5/20/2015 10:18:03,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],pretest,n/a,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853341,5/20/2015 10:19:34,1639608772,5/20/2015 10:16:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],In patients with,n/a,92,58,1,103,74,TWrex-cause,813381-FS1,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA
723853342,5/20/2015 10:35:46,1639614211,5/20/2015 10:35:34,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[IS_A],[IS_A],in,N/A,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 10:42:08,1639616312,5/20/2015 10:41:17,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],in,N/A,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 10:52:23,1639619574,5/20/2015 10:52:02,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION] [IS_A] [OTHER] [SYMPTOM],"[LOCATION]
[SYMPTOM]
[IS_A]
[OTHER]","C, Jansson improved THERAPY IDDM",N/A,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 10:53:25,1639619871,5/20/2015 10:52:55,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],THERAPY in,N/A,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 11:12:40,1639625753,5/20/2015 11:10:13,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],INULIN LISPRO THERAPY in IDDM,na,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 11:13:35,1639625975,5/20/2015 11:13:18,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],IDDM,none,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 12:20:38,1639646721,5/20/2015 12:19:49,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",control THERAPY in,n/a,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 12:21:08,1639646897,5/20/2015 12:20:35,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],control,none,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 12:41:01,1639654109,5/20/2015 12:40:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Strategies toward improved control during INULIN LISPRO THERAPY in IDDM,n/a,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 12:45:50,1639655825,5/20/2015 12:45:03,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],THERAPY,na,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 12:55:37,1639659604,5/20/2015 12:55:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],control during INULIN LISPRO THERAPY in IDDM,n/a,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 12:57:32,1639660418,5/20/2015 12:57:10,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[TREATS],[TREATS],INULIN LISPRO THERAPY IDDM,n/a,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 12:59:41,1639661402,5/20/2015 12:59:29,false,instagc,1.0,23035364,USA,NJ,Voorhees,50.153.124.129,[TREATS],[TREATS],control,N/A,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 13:01:14,1639661959,5/20/2015 12:59:36,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],n/a,none specified,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853342,5/20/2015 13:01:16,1639661960,5/20/2015 13:00:55,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,N/A,105,80,-1,108,101,TWrex-cause,804036-FS1,"Ebeling P, Lalli C, Jansson PA et al. Strategies toward improved control during INULIN LISPRO THERAPY in IDDM",IDDM,INULIN LISPRO THERAPY
723853343,5/20/2015 08:10:05,1639569988,5/20/2015 08:09:04,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SIDE_EFFECT],[SIDE_EFFECT],DRUGS; accidental olanzapine OVERDOSE,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 08:11:33,1639570507,5/20/2015 08:10:53,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SIDE_EFFECT],[SIDE_EFFECT],reactions,NA,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 08:12:50,1639570830,5/20/2015 08:12:34,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reactions,n/a,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 08:14:28,1639571308,5/20/2015 08:13:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],reactions to,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 08:15:01,1639571435,5/20/2015 08:14:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],reactions,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 08:41:58,1639579747,5/20/2015 08:41:28,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],accidental,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 08:49:27,1639582257,5/20/2015 08:48:29,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reactions to,n/a,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 08:58:37,1639584724,5/20/2015 08:56:05,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],accidental OVERDOSE,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 09:08:34,1639587291,5/20/2015 09:08:11,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,Unrelated terms.,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 09:16:32,1639589474,5/20/2015 09:14:30,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],accidental,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 09:36:12,1639595116,5/20/2015 09:35:38,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],accidental,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 09:40:44,1639596547,5/20/2015 09:40:01,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[NONE],[NONE],N/A,Is referring to another situation,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 09:47:00,1639598336,5/20/2015 09:46:38,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[MANIFESTATION],[MANIFESTATION],Cutaneous reactions,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 09:51:00,1639599650,5/20/2015 09:50:21,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SIDE_EFFECT],[SIDE_EFFECT],reactions,N/A,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853343,5/20/2015 10:03:30,1639603463,5/20/2015 10:02:41,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],reactions to PSYCHOTROPIC DRUGS;,n/a,108,23,1,115,41,TWrex-cause,812177-FS1,Cutaneous reactions to PSYCHOTROPIC DRUGS; atrial fibrillation and anabolic steroids; accidental olanzapine OVERDOSE in a child.,OVERDOSE,PSYCHOTROPIC DRUGS
723853344,5/20/2015 13:12:55,1639665994,5/20/2015 13:12:32,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],CAUSES,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 13:46:01,1639673567,5/20/2015 13:45:04,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [PREVENTS] [CONTRAINDICATES],"[TREATS]
[PREVENTS]
[CONTRAINDICATES]",many common otologic,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 13:48:44,1639674324,5/20/2015 13:47:51,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [SYMPTOM] [SIDE_EFFECT] [CAUSES],"[CAUSES]
[LOCATION]
[SYMPTOM]
[SIDE_EFFECT]",recommendation: Consult Constant CAUSES involves,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 13:49:12,1639674469,5/20/2015 13:48:58,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[MANIFESTATION] [CONTRAINDICATES],"[MANIFESTATION]
[CONTRAINDICATES]",recommendation:,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:07:02,1639679467,5/20/2015 14:05:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HAS many common,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:27:43,1639686182,5/20/2015 14:26:05,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],EAR PAIN HAS many common otologic CAUSES AND NEURALGIA,n/a,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:32:13,1639687539,5/20/2015 14:31:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],common otologic CAUSES,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:34:13,1639688302,5/20/2015 14:31:53,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],EAR PAIN HAS CAUSES AND NEURALGIA THat involves the ear is rare.,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:37:31,1639689377,5/20/2015 14:36:42,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],CAUSES,n/a,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:55:28,1639695222,5/20/2015 14:55:01,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],otologic CAUSES,n/a,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:56:42,1639695735,5/20/2015 14:55:34,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[CAUSES],[CAUSES],EAR PAIN HAS many common CAUSES AND NEURALGIA is rare.,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:57:35,1639696040,5/20/2015 14:56:41,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],CAUSES,n/a,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:59:17,1639696613,5/20/2015 14:58:25,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],CAUSES,N/A,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 14:59:47,1639696746,5/20/2015 14:59:19,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves ear rare.,na,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853344,5/20/2015 15:17:15,1639702628,5/20/2015 15:16:05,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[NONE] [OTHER],"[OTHER]
[NONE]",N/A,The two terms are related but the quoting is incorrect and incoherent.,203,237,1,214,260,TWrex-cause,814873-FS1,C]  Specific recommendation:  Consult an ENT specialist if the patient has: ; Pain in the ear or throat ; Constant facial pain with sinus tenderness ; Foul nasal discharge ; Facial swelling  Rationale:  EAR PAIN HAS many common otologic CAUSES AND NEURALGIA THat involves the ear is rare.,EAR PAIN HAS,CAUSES AND NEURALGIA TH
723853345,5/20/2015 10:19:17,1639608668,5/20/2015 10:18:45,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A] [SYMPTOM],"[SYMPTOM]
[IS_A]",has been reported,n/a,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:22:11,1639609683,5/20/2015 10:21:52,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],also known as,n/a,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:26:55,1639611309,5/20/2015 10:26:20,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SIDE_EFFECT],[SIDE_EFFECT],"reported with nearly all anti infectives,",N/A,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:29:09,1639611994,5/20/2015 10:27:25,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],may range in severity from,n/a,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:29:29,1639612093,5/20/2015 10:29:13,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[IS_A],[IS_A],known,N/A,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:29:44,1639612201,5/20/2015 10:29:16,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[ASSOCIATED_WITH],[ASSOCIATED_WITH],range,N/A,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:31:12,1639612630,5/20/2015 10:30:09,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",has been reported with,N/A,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:39:42,1639615552,5/20/2015 10:39:21,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PREVENTS] [LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [SYMPTOM],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]
[SYMPTOM]",Clostridium colitis (CDAD; ANTIBIOTIC ASSOCIATED DIARRHEA reported,N/A,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:42:34,1639616461,5/20/2015 10:41:40,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],ANTIBIOTIC ASSOCIATED DIARRHEA may range from mild DIARRHEA to fatal colitis.,na,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:44:32,1639617008,5/20/2015 10:42:55,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],been reported,na,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:54:35,1639620237,5/20/2015 10:54:12,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[IS_A],[IS_A],also known as,N/A,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 10:59:48,1639621799,5/20/2015 10:58:55,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[SIDE_EFFECT],[SIDE_EFFECT],ASSOCIATED,-,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 11:06:02,1639623902,5/20/2015 11:05:13,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],(CDAD;,none,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 11:16:18,1639626758,5/20/2015 11:14:30,false,clixsense,1.0,7074645,USA,"","",73.221.254.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853345,5/20/2015 11:40:09,1639633638,5/20/2015 11:37:34,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[OTHER],[OTHER],also known as,Also known as,121,99,1,128,129,TWrex-cause,814631-FS1,"100 ,   120 ,   121    Clostridium difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefadroxil, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
723853346,5/20/2015 10:19:28,1639608725,5/20/2015 10:19:18,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:22:31,1639609812,5/20/2015 10:22:12,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],Treatment,n/a,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:27:39,1639611563,5/20/2015 10:26:56,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],Treatment of,N/A,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:29:33,1639612099,5/20/2015 10:29:10,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Treatment of,n/a,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:29:44,1639612199,5/20/2015 10:29:31,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],drug,N/A,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:30:34,1639612447,5/20/2015 10:29:46,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Treatment,N/A,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:32:18,1639613012,5/20/2015 10:31:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],Treatment of,N/A,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:40:13,1639615776,5/20/2015 10:39:45,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PREVENTS] [CAUSES] [LOCATION],"[PREVENTS]
[CAUSES]
[LOCATION]","Arrhythmias ARRHYTHMIAS threatening, drug ANTIARRHYTHMIC",N/A,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:44:46,1639617071,5/20/2015 10:42:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Treatment of VENTRICULAR ARRHYTHMIAS drug ANTIARRHYTHMIC,na,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:45:10,1639617215,5/20/2015 10:44:34,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],drug,na,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 10:55:51,1639620662,5/20/2015 10:54:36,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CONTRAINDICATES],[CONTRAINDICATES],not,N/A,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 11:00:16,1639621988,5/20/2015 10:59:49,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],Treatment,-,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 11:06:32,1639624052,5/20/2015 11:06:03,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],ANTIARRHYTHMIC,none,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 11:17:39,1639627155,5/20/2015 11:16:18,false,clixsense,1.0,7074645,USA,"","",73.221.254.240,[TREATS],[TREATS],judgment,n/a,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853346,5/20/2015 11:52:00,1639636733,5/20/2015 11:50:39,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug first choice.,n/a,51,188,-1,73,202,TWrex-cause,804830-FS1,"b  Ventricular Arrhythmias (General)  Treatment of VENTRICULAR ARRHYTHMIAS (e.g., sustained VT) that in the judgment of the clinician are life threatening, but the drug usually is not the ANTIARRHYTHMIC of first choice.",VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC
723853347,5/20/2015 10:36:45,1639614643,5/20/2015 10:36:34,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],for,N/A,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 10:44:13,1639616919,5/20/2015 10:43:42,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],for,N/A,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 10:55:44,1639620605,5/20/2015 10:55:03,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BENIGN,N/A,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 10:58:20,1639621437,5/20/2015 10:57:54,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 11:15:18,1639626358,5/20/2015 11:14:43,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],TERAZOSIN,none,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 11:17:40,1639627181,5/20/2015 11:17:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,na,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 12:23:50,1639647972,5/20/2015 12:23:23,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],for,none,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 12:24:07,1639648069,5/20/2015 12:23:34,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PREVENTS],[PREVENTS],for,n/a,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 12:43:21,1639654939,5/20/2015 12:42:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,n/a,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 12:47:41,1639656564,5/20/2015 12:47:24,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],for,na,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 12:57:32,1639660421,5/20/2015 12:57:19,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,n/a,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 13:02:26,1639662418,5/20/2015 13:02:04,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],for,N/A,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 13:03:11,1639662718,5/20/2015 13:01:53,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[OTHER],[OTHER],for,n/a,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 13:03:25,1639662793,5/20/2015 13:02:44,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",for,N/A,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853347,5/20/2015 13:03:55,1639662972,5/20/2015 13:03:08,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[TREATS],[TREATS],for,n/a,14,0,-1,41,9,TWrex-cause,804711-FS1,TERAZOSIN for BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
723853348,5/20/2015 10:36:04,1639614301,5/20/2015 10:35:48,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PART_OF],[PART_OF],(12%,N/A,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 10:42:48,1639616499,5/20/2015 10:42:09,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],compared,N/A,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 10:52:48,1639619670,5/20/2015 10:52:26,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [CONTRAINDICATES] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]
[CONTRAINDICATES]",compared LIPOSOMAL AMPHOTERICIN (12%,N/A,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 10:56:13,1639620733,5/20/2015 10:53:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],as effective as,N/A,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 11:14:06,1639626152,5/20/2015 11:12:42,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],LIPOSOMAL AMPHOTERICIN B in patients NEUTROPENIC,na,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 11:14:08,1639626154,5/20/2015 11:13:35,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],NEUTROPENIC,none,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 12:21:42,1639647130,5/20/2015 12:20:39,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",study with effective associated with,n/a,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 12:22:31,1639647500,5/20/2015 12:21:08,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],effective,none,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 12:41:47,1639654369,5/20/2015 12:41:02,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events,n/a,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 12:46:24,1639656084,5/20/2015 12:45:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],as effective,na,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 12:56:21,1639659911,5/20/2015 12:55:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],LIPOSOMAL AMPHOTERICIN (12% NEUTROPENIC,n/a,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 12:59:10,1639661132,5/20/2015 12:57:34,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[TREATS],[TREATS],as effective,n/a,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 13:00:01,1639661491,5/20/2015 12:59:42,false,instagc,1.0,23035364,USA,NJ,Voorhees,50.153.124.129,[TREATS],[TREATS],effective,N/A,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 13:00:19,1639661665,5/20/2015 12:59:53,false,elite,1,31913360,USA,DE,"",108.59.8.217,[CAUSES],[CAUSES],patients,ghg,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853348,5/20/2015 13:02:41,1639662487,5/20/2015 13:00:57,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[CAUSES] [MANIFESTATION] [ASSOCIATED_WITH],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",micafungin was as effective as liposomal,N/A,85,39,-1,95,63,TWrex-cause,800476-FS1,In study that compared micafungin with LIPOSOMAL AMPHOTERICIN B in 531 patients (12% NEUTROPENIC micafungin was as effective as liposomal amphotericin B but was associated with fewer adverse events ( 206.,NEUTROPENIC,LIPOSOMAL AMPHOTERICIN B
723853349,5/20/2015 08:18:46,1639572596,5/20/2015 08:18:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],prophylaxis,n/a,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 08:22:04,1639573689,5/20/2015 08:21:40,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analysis,N,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 08:25:24,1639574826,5/20/2015 08:24:25,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",and prophylaxis with,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 08:25:52,1639574936,5/20/2015 08:25:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analysis of risk factors,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 08:39:28,1639578852,5/20/2015 08:38:21,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],GRAFT VERSUS HOST DISEASE: risk factors after transplantation prophylaxis with CYCLOSPORINE,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 09:15:48,1639589260,5/20/2015 09:15:26,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],prophylaxis with,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 09:17:22,1639589731,5/20/2015 09:15:24,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER] [TREATS],"[TREATS]
[OTHER]",Acute GRAFT VERSUS HOST DISEASE: marrow transplantation and prophylaxis with,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 09:32:21,1639593989,5/20/2015 09:32:01,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],prophylaxis,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 09:53:22,1639600379,5/20/2015 09:52:34,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],after allogeneic marrow transplantation,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 09:55:18,1639600943,5/20/2015 09:54:58,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],transplantation,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 10:05:07,1639603996,5/20/2015 10:04:42,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],prophylaxis with,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 10:08:54,1639605003,5/20/2015 10:07:44,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analysis,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 10:17:17,1639608010,5/20/2015 10:16:42,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],with,n/a,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 10:20:06,1639608966,5/20/2015 10:19:29,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],after,n/a,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853349,5/20/2015 10:23:59,1639610277,5/20/2015 10:23:30,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],prophylaxis with,N/A,40,153,-1,64,165,TWrex-cause,804679-FS1,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE
723853350,5/20/2015 13:13:13,1639666081,5/20/2015 13:12:56,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],prevention,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 13:47:29,1639673977,5/20/2015 13:46:07,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]","evaluating combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of",N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 13:49:27,1639674539,5/20/2015 13:49:13,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[PREVENTS],[PREVENTS],outcomes,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 13:49:31,1639674706,5/20/2015 13:48:46,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [LOCATION] [SYMPTOM] [SIDE_EFFECT],"[CAUSES]
[LOCATION]
[SYMPTOM]
[SIDE_EFFECT]",STUDY SELECTION Studies (RCTs) death.,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:08:21,1639679799,5/20/2015 14:07:04,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],for prevention,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:27:55,1639686242,5/20/2015 14:27:45,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[PREVENTS],[PREVENTS],WARFARIN prevention of THROMBOEMBOLISM,n/a,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:32:43,1639687767,5/20/2015 14:32:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],prevention of,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:36:15,1639688978,5/20/2015 14:34:14,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],low dose warfarin for prevention of THROMBOEMBOLISM,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:38:05,1639689566,5/20/2015 14:37:32,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevention,n/a,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:55:53,1639695368,5/20/2015 14:55:29,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],prevention,n/a,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:57:14,1639695913,5/20/2015 14:56:45,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[PREVENTS],[PREVENTS],WARFARIN prevention of THROMBOEMBOLISM,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:58:28,1639696375,5/20/2015 14:57:36,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[PREVENTS],[PREVENTS],for prevention of,n/a,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 14:59:38,1639696699,5/20/2015 14:59:18,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],prevention,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 15:00:07,1639696844,5/20/2015 14:59:48,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"WARFARIN aspirin, combined dose warfarin and aspirin, molecular weight or prevention THROMBOEMBOLISM flutter and outcomes stroke, bleeding,",na,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853350,5/20/2015 15:18:09,1639702861,5/20/2015 15:17:42,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[PREVENTS],[PREVENTS],for prevention of,N/A,218,99,-1,232,107,TWrex-cause,804437-FS1,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) evaluating WARFARIN aspirin, combined low dose warfarin and aspirin, low molecular weight heparin, or indobufen for prevention of THROMBOEMBOLISM in AF or atrial flutter and if the outcomes were stroke, major bleeding, or death.",THROMBOEMBOLISM,WARFARIN
723853351,5/20/2015 08:13:36,1639571049,5/20/2015 08:12:49,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],disorders include,N,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 08:14:08,1639571219,5/20/2015 08:13:41,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 08:16:26,1639571942,5/20/2015 08:15:43,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],These disorders include,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 08:16:33,1639572008,5/20/2015 08:16:13,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],and,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 08:27:13,1639575239,5/20/2015 08:26:13,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 08:44:06,1639580451,5/20/2015 08:43:15,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 08:55:14,1639583804,5/20/2015 08:52:22,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],n/a,no relationship specified,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 09:01:35,1639585535,5/20/2015 09:00:17,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],and,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 09:10:05,1639587626,5/20/2015 09:09:30,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,Two unrelated terms.,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 09:21:33,1639590823,5/20/2015 09:20:40,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],noninflammatory arteriopathies,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 09:39:40,1639596245,5/20/2015 09:38:38,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],These disorders include,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 09:41:34,1639596753,5/20/2015 09:41:20,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[OTHER],[OTHER],and,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 09:48:30,1639598819,5/20/2015 09:48:01,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],SAH.,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 09:57:09,1639601469,5/20/2015 09:55:59,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],include,N/A,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853351,5/20/2015 10:06:18,1639604345,5/20/2015 10:03:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,various arteriopathies are listed,329,357,1,347,323,TWrex-cause,813789-FS1,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS
723853352,5/20/2015 08:03:28,1639567753,5/20/2015 08:02:17,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],METFORMIN Can accumulate in patients who develop rENAL FAILURE,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 08:05:29,1639568498,5/20/2015 08:05:02,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],lead,NA,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 08:08:46,1639569589,5/20/2015 08:08:00,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]",Can accumulate in patients who develop,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 08:10:03,1639569975,5/20/2015 08:09:08,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accumulate,n/a,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 08:11:33,1639570510,5/20/2015 08:10:57,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],Can accumulate,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 08:38:03,1639578497,5/20/2015 08:37:41,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],accumulate,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 08:40:49,1639579256,5/20/2015 08:38:19,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[SIDE_EFFECT],[SIDE_EFFECT],can lead to,n/a,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 08:49:28,1639582265,5/20/2015 08:48:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],accumulate in patients who develop,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 09:04:59,1639586365,5/20/2015 09:04:40,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[MANIFESTATION],[MANIFESTATION],Can accumulate in patients who develop,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 09:10:55,1639587859,5/20/2015 09:09:08,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CONTRAINDICATES],[CONTRAINDICATES],metformin accumulation can be fatal.,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 09:30:23,1639593215,5/20/2015 09:30:01,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Can accumulate,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 09:37:52,1639595658,5/20/2015 09:37:13,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",Can accumulate in patients who develop,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 09:42:11,1639596936,5/20/2015 09:40:19,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],accumulate lead,why I didn't select none,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 09:43:05,1639597163,5/20/2015 09:42:21,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[MANIFESTATION],[MANIFESTATION],accumulation,N/A,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853352,5/20/2015 09:59:33,1639602236,5/20/2015 09:58:39,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],accumulation can be fatal.,n/a,51,2,-1,62,12,TWrex-cause,803196-FS1," METFORMIN Can accumulate in patients who develop rENAL FAILURE and metformin accumulation can lead to lactic acidosis, which can be fatal.",ENAL FAILURE,ETFORMIN C
723853353,5/20/2015 08:05:54,1639568666,5/20/2015 08:04:58,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ACUTE MYELOGENOUS LEUKEMIA continuous infusion high dose DAUNORUBICIN:,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 08:06:47,1639568925,5/20/2015 08:06:24,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed,NA,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 08:10:11,1639570021,5/20/2015 08:09:39,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment of newly diagnosed,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 08:11:02,1639570325,5/20/2015 08:10:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment,n/a,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 08:12:27,1639570751,5/20/2015 08:12:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Treatment,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 08:39:35,1639578896,5/20/2015 08:38:47,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[SYMPTOM],[SYMPTOM],during,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 08:43:48,1639580420,5/20/2015 08:42:12,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],N/A,doesn't specify a relationship.,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 08:52:16,1639583094,5/20/2015 08:50:40,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],continuous infusion,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 09:06:29,1639586788,5/20/2015 09:06:01,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],Treatment of with,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 09:12:24,1639588258,5/20/2015 09:11:53,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Treatment,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 09:32:09,1639593919,5/20/2015 09:31:33,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Treatment of,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 09:38:42,1639595970,5/20/2015 09:38:25,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],Treatment of,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 09:44:16,1639597493,5/20/2015 09:43:56,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],Treatment,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 09:45:07,1639597671,5/20/2015 09:44:02,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Treatment diagnosed,didn't select none,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853353,5/20/2015 10:01:09,1639602704,5/20/2015 10:00:20,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],continuous high dose,N/A,68,214,-1,93,226,TWrex-cause,804286-FS1,"Estey E, Thall PF, Kantarjian H et al. Treatment of newly diagnosed ACUTE MYELOGENOUS LEUKEMIA with granulocyte macrophage colony stimulating factor (GM CSF) before and during continuous infusion high dose Ara C + DAUNORUBICIN: comparison to patients treated without GM CSF.",ACUTE MYELOGENOUS LEUKEMIA,DAUNORUBICIN
723853354,5/20/2015 08:12:47,1639570810,5/20/2015 08:12:15,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[ASSOCIATED_WITH],[ASSOCIATED_WITH],multiple,N,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 08:13:39,1639571051,5/20/2015 08:13:12,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 08:15:41,1639571737,5/20/2015 08:15:12,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and 5.8% had,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 08:16:12,1639571894,5/20/2015 08:15:32,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],and,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 08:26:11,1639575007,5/20/2015 08:24:36,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[OTHER],[OTHER],TYPE (MEN I) had MALIGNANT INSULINOMA,test of how many people have a condition,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 08:43:14,1639580183,5/20/2015 08:42:23,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[PART_OF],[PART_OF],Of,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 08:52:20,1639583125,5/20/2015 08:51:07,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],N/A,No relationship,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 09:00:16,1639585219,5/20/2015 08:59:14,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],and,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 09:09:29,1639587469,5/20/2015 09:09:05,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,Unrelated terms,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 09:20:39,1639590593,5/20/2015 09:19:57,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],"patients, had",N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 09:38:35,1639595919,5/20/2015 09:37:23,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and 5.8% had,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 09:41:19,1639596685,5/20/2015 09:41:02,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[OTHER],[OTHER],and,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 09:48:00,1639598672,5/20/2015 09:47:26,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],MALIGNANT INSULINOMA,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 09:55:57,1639601111,5/20/2015 09:55:36,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[IS_A],[IS_A],had,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853354,5/20/2015 10:04:09,1639603749,5/20/2015 10:03:23,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[ASSOCIATED_WITH],[ASSOCIATED_WITH],had and had,N/A,87,59,1,106,73,TWrex-cause,813551-FS1,"Of the 224 patients, 7.6% had multiple endocrine neoplasia TYPE I (MEN I) and 5.8% had MALIGNANT INSULINOMA",MALIGNANT INSULINOMA,TYPE I (MEN I)
723853355,5/20/2015 08:15:55,1639571817,5/20/2015 08:15:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],protects against,n/a,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 08:17:44,1639572291,5/20/2015 08:16:49,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[PREVENTS],[PREVENTS],protects,N,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 08:19:28,1639572858,5/20/2015 08:19:00,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],protects against,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 08:19:48,1639572995,5/20/2015 08:19:30,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],protects against,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 08:33:09,1639576922,5/20/2015 08:32:14,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],VITAMIN E protects against ALZHEIMER'S DISEASE,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 08:47:19,1639581567,5/20/2015 08:46:55,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[PREVENTS],[PREVENTS],protects,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 09:04:39,1639586318,5/20/2015 09:03:59,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[PREVENTS],[PREVENTS],protects against,n/a,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 09:08:34,1639587293,5/20/2015 09:08:11,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],protects against,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 09:12:16,1639588236,5/20/2015 09:12:02,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[PREVENTS],[PREVENTS],protects against,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 09:25:33,1639591782,5/20/2015 09:25:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],protects against controversial.,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 09:44:36,1639597588,5/20/2015 09:44:10,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PREVENTS],[PREVENTS],protects against,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 09:48:30,1639598820,5/20/2015 09:48:13,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[PREVENTS],[PREVENTS],protects against,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 09:51:41,1639599754,5/20/2015 09:51:12,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[PREVENTS],[PREVENTS],protects,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 10:02:00,1639603039,5/20/2015 10:01:22,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],protects,N/A,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853355,5/20/2015 10:10:32,1639605608,5/20/2015 10:09:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],protects against,n/a,61,8,-1,79,17,TWrex-cause,805257-FS1,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E
723853356,5/20/2015 13:13:38,1639666219,5/20/2015 13:13:30,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 13:50:01,1639674726,5/20/2015 13:49:45,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],serious,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 13:50:25,1639674902,5/20/2015 13:49:45,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[CAUSES],[CAUSES],May cause serious,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 13:51:05,1639675052,5/20/2015 13:50:27,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES],[CAUSES],VZV cause iNFECTION adult,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 14:11:18,1639680784,5/20/2015 14:09:45,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],cause,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 14:28:39,1639686404,5/20/2015 14:28:11,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],VZV May cause serious iNFECTION,n/a,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 14:34:59,1639688565,5/20/2015 14:33:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],cause,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 14:38:07,1639689573,5/20/2015 14:37:26,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],VZV May cause iNFECTION,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 14:39:33,1639690107,5/20/2015 14:39:13,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],cause,n/a,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 14:56:45,1639695746,5/20/2015 14:56:24,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],May cause,n/a,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 15:00:37,1639697007,5/20/2015 14:59:17,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[CAUSES],[CAUSES],VZV cause iNFECTION,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 15:00:43,1639697020,5/20/2015 15:00:25,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],VZV cause serious iNFECTION,na,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 15:02:01,1639697443,5/20/2015 15:00:58,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],cause,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 15:02:52,1639697727,5/20/2015 15:00:58,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],cause,n/a,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853356,5/20/2015 15:20:42,1639703712,5/20/2015 15:20:22,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES],[CAUSES],May cause,N/A,24,1,1,31,6,TWrex-cause,811099-FS1," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M
723853357,5/20/2015 08:04:17,1639568043,5/20/2015 08:03:30,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PELVIC PAIN associated with ENDOMETRIOSIS,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 08:05:57,1639568682,5/20/2015 08:05:30,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],dose,NA,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 08:09:08,1639569717,5/20/2015 08:08:48,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 08:10:23,1639570090,5/20/2015 08:10:04,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",associated with,n/a,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 08:11:55,1639570599,5/20/2015 08:11:34,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 08:38:22,1639578585,5/20/2015 08:38:04,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 08:41:22,1639579514,5/20/2015 08:40:51,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 08:50:16,1639582509,5/20/2015 08:49:30,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 09:05:20,1639586476,5/20/2015 09:05:01,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[SYMPTOM],[SYMPTOM],associated with,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 09:11:24,1639587949,5/20/2015 09:10:57,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 09:30:53,1639593396,5/20/2015 09:30:24,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 09:38:05,1639595717,5/20/2015 09:37:53,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 09:42:57,1639597141,5/20/2015 09:42:13,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,didn't select none,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 09:43:28,1639597268,5/20/2015 09:43:07,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853357,5/20/2015 09:59:59,1639602375,5/20/2015 09:59:34,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,161,189,1,171,202,TWrex-cause,814246-FS1,"1]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for PELVIC PAIN associated with ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
723853358,5/20/2015 13:52:08,1639675455,5/20/2015 13:51:56,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],tip of the nose,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 14:05:53,1639679107,5/20/2015 14:05:00,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [LOCATION] [PART_OF] [SIDE_EFFECT],"[LOCATION]
[SIDE_EFFECT]
[IS_A]
[PART_OF]",of in the is a NEURALGIA HERPES,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 14:22:48,1639684530,5/20/2015 14:21:33,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],condition of,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 14:42:09,1639690853,5/20/2015 14:41:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],condition of,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 14:44:30,1639691683,5/20/2015 14:44:12,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],Involvement,n/a,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 14:56:05,1639695478,5/20/2015 14:54:20,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PART_OF],[PART_OF],POSTHERPETIC NEURALGIA a condition CHRONIC PAIN FOLLOWING HERPES,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 15:02:31,1639697585,5/20/2015 15:01:55,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[IS_A],[IS_A],a condition of,n/a,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 15:16:52,1639702505,5/20/2015 15:14:07,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],a condition of,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 15:25:01,1639705203,5/20/2015 15:24:41,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],POSTHERPETIC NEURALGIA condition CHRONIC PAIN FOLLOWING HERPES zoster.,na,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 15:26:57,1639705749,5/20/2015 15:26:28,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[IS_A],[IS_A],a condition of,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 15:30:28,1639706788,5/20/2015 15:29:56,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],POSTHERPETIC NEURALGIA a condition of CHRONIC PAIN FOLLOWING HERPES,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 15:35:12,1639708101,5/20/2015 15:34:54,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[MANIFESTATION],[MANIFESTATION],POSTHERPETIC NEURALGIA a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,N/A,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 16:13:46,1639720172,5/20/2015 16:13:20,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],a condition of,n/a,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 16:27:31,1639724403,5/20/2015 16:27:14,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],condition of,n/a,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853358,5/20/2015 16:46:53,1639732185,5/20/2015 16:45:26,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],a condition of,n/a,145,105,1,173,127,TWrex-cause,813399-FS1,Involvement of the tip of the nose in the zoster rash is a strong predictor of herpes ophthalmicus.[46]  POSTHERPETIC NEURALGIA   a condition of CHRONIC PAIN FOLLOWING HERPES zoster.,CHRONIC PAIN FOLLOWING HERPES,POSTHERPETIC NEURALGIA
723853359,5/20/2015 08:17:12,1639572161,5/20/2015 08:16:54,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],long term treatment,n/a,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 08:20:04,1639573080,5/20/2015 08:19:42,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,NA,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 08:22:51,1639573931,5/20/2015 08:22:21,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for the long term treatment of,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 08:23:28,1639574243,5/20/2015 08:21:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 08:36:20,1639577888,5/20/2015 08:35:41,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],THERAPY WITH WARFARIN treatment of vENOUS THROMBOSIS,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 09:12:26,1639588262,5/20/2015 09:11:40,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for the long term treatment of,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 09:13:55,1639588732,5/20/2015 09:13:37,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],for the long term treatment of,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 09:28:36,1639592502,5/20/2015 09:28:14,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Therapy,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 09:49:34,1639599248,5/20/2015 09:49:06,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],long term treatment,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 09:49:54,1639599391,5/20/2015 09:49:38,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],the long term treatment of,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 09:53:58,1639600567,5/20/2015 09:53:37,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[PREVENTS],[PREVENTS],lower risk,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 10:05:24,1639604105,5/20/2015 10:04:25,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS] [PREVENTS] [ASSOCIATED_WITH],"[TREATS]
[PREVENTS]
[ASSOCIATED_WITH]",treatment associated with,N/A,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 10:15:02,1639607166,5/20/2015 10:14:46,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 10:16:56,1639607855,5/20/2015 10:16:32,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for the long term treatment of,n/a,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853359,5/20/2015 10:18:03,1639608275,5/20/2015 10:17:50,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,111,49,-1,128,72,TWrex-cause,800003-FS1, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T
723853360,5/20/2015 08:14:47,1639571386,5/20/2015 08:14:25,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 08:15:08,1639571477,5/20/2015 08:14:20,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],required,N,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 08:17:25,1639572191,5/20/2015 08:17:02,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],therapy,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 08:17:57,1639572314,5/20/2015 08:17:06,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF],[PART_OF],"(i.e., disease caused by",N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 08:29:25,1639575826,5/20/2015 08:27:56,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT caused by M TUBERCULOSIS,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 08:45:18,1639580854,5/20/2015 08:44:43,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],caused,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 08:58:15,1639584621,5/20/2015 08:57:01,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],"(i.e., disease caused by",n/a,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 09:03:33,1639586000,5/20/2015 09:02:58,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 09:10:57,1639587865,5/20/2015 09:10:27,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],disease caused by,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 09:22:43,1639591066,5/20/2015 09:22:01,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 09:42:09,1639596925,5/20/2015 09:41:02,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],disease disease caused,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 09:44:54,1639597647,5/20/2015 09:44:11,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],"(i.e., disease caused by M TUBERCULOSIS",N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 09:49:17,1639599201,5/20/2015 09:49:00,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],caused,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 09:58:33,1639601880,5/20/2015 09:57:54,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853360,5/20/2015 10:09:52,1639605346,5/20/2015 10:09:05,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],disease caused by M TUBERCULOSIS,n/a,43,136,1,100,150,TWrex-cause,811774-FS1,"Longer courses of therapy are required for DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT disease (i.e., disease caused by  M TUBERCULOSIS  that is resistant to at least isoniazid and rifampin).Treatment of tuberculosis has two phases: initiation (also known as the bactericidal or intensive phase) and continuation (also known as the subsequent sterilizing phase.",DRUG RESISTANT TUBERCULOSIS ESPECIALLY MULTIDRUG RESISTANT,M TUBERCULOSIS
723853361,5/20/2015 10:36:18,1639614414,5/20/2015 10:36:05,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 10:43:11,1639616636,5/20/2015 10:42:50,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",caused by,N/A,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 10:53:27,1639619882,5/20/2015 10:52:50,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION] [PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [SYMPTOM],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]
[SYMPTOM]",568 625 Q caused 625 caused Rickettsia,N/A,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 10:56:49,1639620992,5/20/2015 10:56:16,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 11:14:21,1639626194,5/20/2015 11:14:08,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],COXIELLA BURNETII,none,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 11:16:02,1639626663,5/20/2015 11:14:07,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],Q FEVER ENDOCARDITIS caused by COXIELLA BURNETII,na,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 12:22:16,1639647339,5/20/2015 12:21:43,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",effective caused caused by,n/a,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 12:22:55,1639647605,5/20/2015 12:22:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 12:42:24,1639654576,5/20/2015 12:41:47,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Has been effective for Q FEVER ENDOCARDITIS caused by COXIELLA BURNETII + 625 and Mediterranean spotted fever caused by Rickettsia conorii,n/a,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 12:46:49,1639656208,5/20/2015 12:46:25,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,na,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 12:56:37,1639660027,5/20/2015 12:56:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],Q FEVER ENDOCARDITIS caused by COXIELLA BURNETII,na,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 13:00:12,1639661610,5/20/2015 13:00:02,false,instagc,1.0,23035364,USA,NJ,Voorhees,50.153.124.129,[CAUSES],[CAUSES],caused,N/A,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 13:00:30,1639661702,5/20/2015 13:00:20,false,elite,1.0,31913360,USA,DE,"",108.59.8.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BURNETII,ff,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 13:00:45,1639661851,5/20/2015 12:59:11,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[OTHER],[OTHER],caused by,n/a,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853361,5/20/2015 13:02:08,1639662311,5/20/2015 13:01:17,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],caused by,n/a,37,69,1,56,86,TWrex-cause,810688-FS1,"568 ,   625   Has been effective for Q FEVER ENDOCARDITIS caused by  COXIELLA BURNETII    +     625   and Mediterranean spotted fever caused by  Rickettsia conorii    +.",Q FEVER ENDOCARDITIS,COXIELLA BURNETII
723853362,5/20/2015 10:20:43,1639609192,5/20/2015 10:20:31,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 10:30:08,1639612365,5/20/2015 10:29:38,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES],[CAUSES],caused by,N/A,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 10:31:10,1639612605,5/20/2015 10:30:56,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 10:33:38,1639613508,5/20/2015 10:32:56,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[ASSOCIATED_WITH],[ASSOCIATED_WITH],+,N/A,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 10:35:04,1639613914,5/20/2015 10:33:44,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 10:36:45,1639614631,5/20/2015 10:36:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 10:41:51,1639616200,5/20/2015 10:41:36,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]",TYPHOID caused SALMONELLA,N/A,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 10:47:33,1639618022,5/20/2015 10:47:05,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,na,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 10:52:35,1639619617,5/20/2015 10:50:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],TYPHOID FEVER caused by SALMONELLA TYPHI,na,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 11:01:58,1639622447,5/20/2015 11:01:38,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],caused,-,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 11:07:50,1639624319,5/20/2015 11:07:37,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],SALMONELLA TYPHI,none,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 11:54:47,1639637430,5/20/2015 11:54:39,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused by,n/a,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 11:58:11,1639638605,5/20/2015 11:56:49,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES],[CAUSES],caused by,n/a,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 12:10:25,1639642957,5/20/2015 12:10:13,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853362,5/20/2015 12:10:41,1639643053,5/20/2015 12:10:05,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,76,136,1,88,152,TWrex-cause,810842-FS1,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI
723853363,5/20/2015 08:15:16,1639571560,5/20/2015 08:15:02,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 08:16:15,1639571914,5/20/2015 08:15:41,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],caused,N,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 08:18:08,1639572334,5/20/2015 08:17:51,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 08:18:40,1639572581,5/20/2015 08:18:19,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],usually caused by,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 08:31:15,1639576365,5/20/2015 08:30:29,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],FUNGAL INFECTION caused by FUNGI,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 08:45:59,1639581082,5/20/2015 08:45:38,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],caused,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 09:01:09,1639585469,5/20/2015 08:59:00,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],caused by,n/a,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 09:05:14,1639586450,5/20/2015 09:04:00,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 09:11:24,1639587952,5/20/2015 09:11:12,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],caused by,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 09:23:27,1639591247,5/20/2015 09:23:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 09:43:20,1639597242,5/20/2015 09:42:48,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 09:47:39,1639598562,5/20/2015 09:47:28,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 09:49:56,1639599411,5/20/2015 09:49:41,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[CAUSES],[CAUSES],caused,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 10:00:06,1639602395,5/20/2015 09:59:36,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853363,5/20/2015 10:07:23,1639604615,5/20/2015 10:06:36,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,106,176,1,121,181,TWrex-cause,811018-FS1,"bronchomycosis    (                      audio )  [&dblprime; +  mykes , fungus, +  osis , condition] Any FUNGAL INFECTION of the bronchi or bronchial tubes, usually caused by FUNGI of the genus  Candida.",FUNGAL INFECTION,FUNGI
723853364,5/20/2015 08:08:21,1639569479,5/20/2015 08:07:57,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CEFTRIAXONE therapy in REFRACTORY LYME DISEASE,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 08:09:33,1639569850,5/20/2015 08:08:49,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],effective therapy,NA,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 08:12:13,1639570691,5/20/2015 08:12:01,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy,n/a,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 08:13:24,1639571032,5/20/2015 08:13:04,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],as effective therapy in,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 08:14:04,1639571182,5/20/2015 08:13:47,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],therapy,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 08:41:04,1639579374,5/20/2015 08:40:48,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],therapy,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 08:47:29,1639581587,5/20/2015 08:46:42,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[TREATS],[TREATS],effective therapy,n/a,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 08:55:15,1639583806,5/20/2015 08:54:40,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],effective therapy,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 09:07:45,1639587137,5/20/2015 09:07:31,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],as effective therapy in,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 09:14:04,1639588763,5/20/2015 09:13:47,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],therapy,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 09:35:02,1639594758,5/20/2015 09:34:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],effective therapy,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 09:39:44,1639596275,5/20/2015 09:39:33,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],as effective therapy in,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 09:46:06,1639598038,5/20/2015 09:45:52,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],therapy,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 09:49:25,1639599213,5/20/2015 09:48:35,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],effective therapy,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853364,5/20/2015 10:02:31,1639603188,5/20/2015 10:02:11,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],effective therapy in,N/A,36,0,-1,58,11,TWrex-cause,803937-FS1,CEFTRIAXONE as effective therapy in REFRACTORY LYME DISEASE,REFRACTORY LYME DISEASE,CEFTRIAXONE
723853365,5/20/2015 08:16:34,1639572007,5/20/2015 08:16:19,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,n/a,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 08:19:08,1639572750,5/20/2015 08:18:38,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],Treatment,NA,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 08:21:05,1639573426,5/20/2015 08:20:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Treatment,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 08:21:37,1639573574,5/20/2015 08:21:12,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment by,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 08:34:29,1639577429,5/20/2015 08:34:01,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA:,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 08:48:22,1639581903,5/20/2015 08:48:08,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],Treatment,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 09:10:08,1639587644,5/20/2015 09:09:45,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],Treatment by,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 09:13:01,1639588435,5/20/2015 09:12:46,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],Treatment by,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 09:27:39,1639592223,5/20/2015 09:27:23,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Treatment,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 09:47:53,1639598635,5/20/2015 09:47:25,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Treatment by,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 09:49:19,1639599203,5/20/2015 09:49:04,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],Treatment by THALIDOMIDE of,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 09:53:06,1639600239,5/20/2015 09:52:47,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[TREATS],[TREATS],Treatment,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 10:03:47,1639603603,5/20/2015 10:02:51,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],Treatment by,N/A,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 10:15:15,1639607232,5/20/2015 10:15:03,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853365,5/20/2015 10:15:42,1639607347,5/20/2015 10:14:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Treatment by,n/a,71,56,-1,97,67,TWrex-cause,804502-FS1,"Cherouati K, Claudy A, Souteyrand P et al. Treatment by THALIDOMIDE of CHRONIC MULTIFORME ERYTHEMA: its recurrent and continuous variants.",CHRONIC MULTIFORME ERYTHEMA,THALIDOMIDE
723853366,5/20/2015 12:53:10,1639658578,5/20/2015 12:51:52,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [LOCATION],"[LOCATION]
[MANIFESTATION]","HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",n/a,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 13:10:45,1639665430,5/20/2015 13:10:30,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 13:17:35,1639667283,5/20/2015 13:17:11,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[NONE],[NONE],n/a,The terms are part of a list of exclusion criteria,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 13:19:16,1639667790,5/20/2015 13:18:06,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]","Exclusion criteria were coronary disease,",N/A,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 13:43:22,1639672813,5/20/2015 13:42:47,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [MANIFESTATION] [SIDE_EFFECT] [CONTRAINDICATES],"[LOCATION]
[MANIFESTATION]
[CONTRAINDICATES]
[SIDE_EFFECT]","coronary HEART cardiomyopathy, valvular congenital cardiac transplantation, defibrillator",N/A,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 13:46:54,1639673817,5/20/2015 13:46:34,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[MANIFESTATION] [CONTRAINDICATES],"[MANIFESTATION]
[CONTRAINDICATES]",Exclusion criteria,N/A,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 13:52:15,1639675478,5/20/2015 13:50:54,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],"use,",N/A,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 14:06:50,1639679415,5/20/2015 14:05:50,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],"Exclusion criteria were HEART FAILURE use,",N/A,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 14:22:45,1639684496,5/20/2015 14:22:30,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[SYMPTOM],[SYMPTOM],"HEART FAILURE DIGITALIS use,",n/a,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 14:27:59,1639686260,5/20/2015 14:26:23,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Exclusion criteria,N/A,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 14:33:11,1639687911,5/20/2015 14:32:36,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"use,",n/a,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 14:46:23,1639692323,5/20/2015 14:43:42,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[NONE],[NONE],N/A,They are exclusion criteria for coronary disease,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 14:51:14,1639693906,5/20/2015 14:49:44,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],"use,",n/a,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 14:51:24,1639693953,5/20/2015 14:49:08,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],Exclusion criteria,n/a,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853366,5/20/2015 14:51:29,1639693966,5/20/2015 14:49:43,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],"HEART FAILURE DIGITALIS use,",N/A,42,209,-1,54,218,TWrex-cause,805062-FS1,"Exclusion criteria were coronary disease, HEART FAILURE left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, DIGITALIS use, pacemaker or defibrillator placement, or end stage renal disease.",HEART FAILURE,DIGITALIS
723853367,5/20/2015 10:20:01,1639608900,5/20/2015 10:19:29,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],for,n/a,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:23:32,1639610084,5/20/2015 10:22:33,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,"diphenhydramine is a treatment, but not for motion sickness",319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:28:38,1639611887,5/20/2015 10:27:40,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[NONE],[NONE],N/A,Both included in a list of treatments for ailments,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:30:26,1639612421,5/20/2015 10:29:45,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PREVENTS],[PREVENTS],malathion,www.givakt.se,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:31:10,1639612612,5/20/2015 10:29:34,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different drugs for different conditions are listed,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:31:34,1639612785,5/20/2015 10:30:36,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],applied,N/A,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:35:19,1639614035,5/20/2015 10:32:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,"Both are listed as examples, but there's no relation.",319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:40:37,1639615885,5/20/2015 10:40:15,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[SYMPTOM] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]",used caregivers applied MOTION,N/A,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:46:04,1639617559,5/20/2015 10:45:12,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],na,na,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 10:47:24,1639617965,5/20/2015 10:44:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],at risk MOTION SICKNESS DIPHENHYDRAMINE,na,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 11:00:50,1639622124,5/20/2015 11:00:17,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[SIDE_EFFECT],[SIDE_EFFECT],toxicity,-,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 11:06:48,1639624105,5/20/2015 11:06:33,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],DIPHENHYDRAMINE,none,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 11:19:41,1639627755,5/20/2015 11:17:39,false,clixsense,1.0,7074645,USA,"","",73.221.254.240,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",exposed,n/a,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 11:53:02,1639637026,5/20/2015 11:52:22,false,neodev,1,29579905,GBR,"","",5.152.206.71,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",occur (numerous with caregivers applied certain,N/A,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853367,5/20/2015 11:54:12,1639637279,5/20/2015 11:52:02,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[NONE],[NONE],none,that drug was associate with another chief complaint.,319,355,-1,333,370,TWrex-cause,805266-FS1,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agents—see  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE
723853368,5/20/2015 10:20:17,1639609060,5/20/2015 10:20:02,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:23:43,1639610204,5/20/2015 10:23:34,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/a,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:29:05,1639611981,5/20/2015 10:28:39,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES],[CAUSES],is caused by,N/A,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:30:40,1639612475,5/20/2015 10:30:28,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:32:26,1639613065,5/20/2015 10:31:37,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[ASSOCIATED_WITH],[ASSOCIATED_WITH],caused,N/A,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:33:19,1639613408,5/20/2015 10:31:12,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],is caused by infection with,n/a,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:35:45,1639614204,5/20/2015 10:35:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:40:54,1639615964,5/20/2015 10:40:39,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",EPIDEMIOLOGY caused RECURRENTIS,N/A,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:46:38,1639617716,5/20/2015 10:46:05,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,na,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 10:48:18,1639618278,5/20/2015 10:47:24,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],EPIDEMIOLOGY LOUSE BORNE RELAPSING FEVER caused by B RECURRENTIS,na,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 11:01:19,1639622284,5/20/2015 11:00:51,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],caused,-,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 11:07:16,1639624185,5/20/2015 11:06:50,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],(LBRF),none,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 11:20:35,1639627989,5/20/2015 11:19:42,false,clixsense,1.0,7074645,USA,"","",73.221.254.240,[CAUSES],[CAUSES],caused,n/a,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 11:55:25,1639637595,5/20/2015 11:54:13,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[SYMPTOM]
[ASSOCIATED_WITH]",caused by infection with,n/a,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853368,5/20/2015 12:10:04,1639642754,5/20/2015 12:09:19,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,14,78,1,40,91,TWrex-cause,810207-FS1,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS
723853369,5/20/2015 10:24:24,1639610400,5/20/2015 10:24:09,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],is a,n/a,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 10:34:05,1639613648,5/20/2015 10:33:54,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 10:37:03,1639614720,5/20/2015 10:35:08,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES],[CAUSES],caused by,N/A,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 10:38:33,1639615139,5/20/2015 10:38:13,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[MANIFESTATION],[MANIFESTATION],caused,N/A,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 10:47:04,1639617886,5/20/2015 10:46:49,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 10:50:11,1639618962,5/20/2015 10:49:14,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",caused RICKETTSIA,N/A,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 11:05:41,1639623802,5/20/2015 11:04:58,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],MITE BORNE DISEASE caused by RICKETTSIA TSUTSUGAMUSHI.,na,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 11:06:36,1639624054,5/20/2015 11:06:24,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],caused,-,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 11:11:31,1639625417,5/20/2015 11:11:14,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],RICKETTSIA TSUTSUGAMUSHI.,none,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 12:10:44,1639643061,5/20/2015 12:09:48,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [MANIFESTATION] [ASSOCIATED_WITH],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",is a caused by,n/a,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 12:17:07,1639645473,5/20/2015 12:16:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 12:32:30,1639651118,5/20/2015 12:31:09,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],Mite Borne Typhus; is a MITE BORNE DISEASE caused by RICKETTSIA TSUTSUGAMUSHI.,N/A,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 12:36:06,1639652348,5/20/2015 12:35:41,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],caused,N/A,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 12:37:03,1639652725,5/20/2015 12:36:19,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Scrub typhus is a MITE BORNE DISEASE caused by RICKETTSIA TSUTSUGAMUSHI.,n/a,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853369,5/20/2015 12:42:33,1639654612,5/20/2015 12:42:10,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,na,93,123,1,110,147,TWrex-cause,810329-FS1,SCRUB TYPHUS  (Tsutsugamushi Disease; Mite Borne Typhus; Tropical Typhus)  Scrub typhus is a MITE BORNE DISEASE caused by  RICKETTSIA TSUTSUGAMUSHI.,MITE BORNE DISEASE,RICKETTSIA TSUTSUGAMUSHI
723853370,5/20/2015 14:45:12,1639691859,5/20/2015 14:44:47,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],INDUCED,n/a,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 15:03:21,1639697955,5/20/2015 15:03:00,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],includes,n/a,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 15:20:11,1639703522,5/20/2015 15:17:13,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],includes,N/A,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 15:27:41,1639706019,5/20/2015 15:27:12,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",includes,N/A,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 15:31:57,1639707146,5/20/2015 15:30:59,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",VIRUS INDUCED DEMYELINATION includes progressive SUBACUTE SCLEROSING PANENCEPHALITIS,N/A,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 15:36:28,1639708618,5/20/2015 15:35:26,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],VIRUS INDUCED DEMYELINATION includes SUBACUTE SCLEROSING PANENCEPHALITIS,N/A,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 16:14:55,1639720529,5/20/2015 16:14:19,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]",includes,n/a,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 16:28:03,1639724630,5/20/2015 16:27:50,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],progressive multifocal,n/a,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 16:48:24,1639732896,5/20/2015 16:48:05,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],includes,n/a,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 16:54:49,1639735848,5/20/2015 16:54:25,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[IS_A],[IS_A],includes,n/a,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 17:11:18,1639743593,5/20/2015 17:10:57,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],includes progressive multifocal leukoencephalopathy and,no comment,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 17:40:50,1639759157,5/20/2015 17:40:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],SCLEROSING PANENCEPHALITIS,N/A,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 18:26:12,1639774584,5/20/2015 18:25:57,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],VIRUS INDUCED DEMYELINATION includes SUBACUTE SCLEROSING PANENCEPHALITIS,na,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 18:37:53,1639778496,5/20/2015 18:37:24,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],includes,N/A,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853370,5/20/2015 18:43:06,1639780809,5/20/2015 18:42:43,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],includes,-,84,0,1,118,27,TWrex-cause,811566-FS1,VIRUS INDUCED DEMYELINATION includes progressive multifocal leukoencephalopathy and SUBACUTE SCLEROSING PANENCEPHALITIS,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS INDUCED DEMYELINATION
723853371,5/20/2015 10:21:29,1639609411,5/20/2015 10:21:07,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],(due to,n/a,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 10:31:07,1639612602,5/20/2015 10:30:31,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",is characterized by,N/A,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 10:31:34,1639612783,5/20/2015 10:31:24,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],vision,N/A,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 10:34:55,1639613882,5/20/2015 10:34:17,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[MANIFESTATION],[MANIFESTATION],characterized,N/A,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 10:37:39,1639614911,5/20/2015 10:36:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],is characterized by,n/a,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 10:39:13,1639615358,5/20/2015 10:37:46,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",characterized by,N/A,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 10:42:37,1639616472,5/20/2015 10:42:14,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[SYMPTOM] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]","Symptoms GALACTOSEMIA retardation, vision LIVER",N/A,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 10:48:41,1639618365,5/20/2015 10:48:22,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],characterized,na,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 10:54:44,1639620267,5/20/2015 10:53:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA characterized by LIVER ENLARGEMENT,na,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 11:03:11,1639622946,5/20/2015 11:02:29,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[SYMPTOM],[SYMPTOM],characterized,-,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 11:08:37,1639624495,5/20/2015 11:08:08,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA,none,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 12:00:48,1639639405,5/20/2015 11:59:08,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM],[SYMPTOM],Symptoms,n/a,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 12:10:55,1639643135,5/20/2015 12:10:40,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 12:11:49,1639643486,5/20/2015 12:11:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],Symptoms,none,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853371,5/20/2015 12:22:21,1639647385,5/20/2015 12:20:58,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES] [ASSOCIATED_WITH] [SIDE_EFFECT],"[CAUSES]
[ASSOCIATED_WITH]
[SIDE_EFFECT]","PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA characterized poor growth mental retardation, speech abnormality, vision impairment LIVER ENLARGEMENT",N/A,203,20,1,219,64,TWrex-cause,812659-FS1,"Symptoms  Galactose 1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA is characterized by poor growth in children, mental retardation, speech abnormality, vision impairment (due to formation of cataract) and LIVER ENLARGEMENT (which may be fatal.",LIVER ENLARGEMENT,1 PHOSPHATE URIDYLYLTRANSFERASE GALACTOSEMIA
723853372,5/20/2015 10:23:15,1639609985,5/20/2015 10:22:59,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],is,n/a,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 10:33:37,1639613494,5/20/2015 10:33:24,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[IS_A],[IS_A],classified,N/A,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 10:34:40,1639613808,5/20/2015 10:34:15,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[IS_A],[IS_A],is classified as,N/A,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 10:37:50,1639614958,5/20/2015 10:37:23,false,prodege,1.0,15439740,AUS,02,Jannali,14.200.59.55,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",classified,N/A,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 10:45:59,1639617530,5/20/2015 10:44:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],classified as,N/A,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 10:47:35,1639618035,5/20/2015 10:46:26,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS] [MANIFESTATION] [SYMPTOM],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[MANIFESTATION]",older than KSS OPHTHALMOPLEGIA,N/A,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 10:52:22,1639619578,5/20/2015 10:51:49,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[PART_OF],[PART_OF],classified as,na,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 11:04:20,1639623376,5/20/2015 11:03:38,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],KSS classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,na,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 11:05:58,1639623896,5/20/2015 11:05:34,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[IS_A],[IS_A],classified,-,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 11:10:51,1639625164,5/20/2015 11:10:30,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],(CPEO.,none,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 12:08:52,1639642379,5/20/2015 12:07:29,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [MANIFESTATION] [PART_OF],"[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",is predominant is classified,n/a,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 12:12:24,1639643716,5/20/2015 12:12:14,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.161,[NONE],[NONE],no,no,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 12:16:02,1639645125,5/20/2015 12:15:11,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],classified,none,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 12:29:13,1639649943,5/20/2015 12:27:47,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[MANIFESTATION] [IS_A],"[MANIFESTATION]
[IS_A]",KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,N/A,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853372,5/20/2015 12:35:19,1639652156,5/20/2015 12:34:54,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],"phenotype,",causes,106,85,1,149,88,TWrex-cause,813430-FS1,"In persons older than 20 years in whom ophthalmoplegia is the predominant phenotype, KSS is classified as CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO.",CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KSS
723853373,5/20/2015 08:14:19,1639571272,5/20/2015 08:13:38,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 08:14:24,1639571289,5/20/2015 08:14:09,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],can precede,n/a,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 08:17:00,1639572108,5/20/2015 08:16:34,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 08:17:04,1639572127,5/20/2015 08:16:28,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],can precede the diagnosis of,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 08:27:55,1639575368,5/20/2015 08:27:16,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEMATURIA can precede the diagnosis of BLADDER CANCER,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 08:44:41,1639580611,5/20/2015 08:44:07,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 08:57:00,1639584277,5/20/2015 08:55:14,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[MANIFESTATION],[MANIFESTATION],can precede,n/a,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 09:02:56,1639585871,5/20/2015 09:01:36,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],can precede the diagnosis of,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 09:10:24,1639587703,5/20/2015 09:10:05,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[MANIFESTATION],[MANIFESTATION],can precede the diagnosis of,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 09:22:00,1639590902,5/20/2015 09:21:35,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],precede the diagnosis,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 09:41:00,1639596619,5/20/2015 09:39:41,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],can precede the diagnosis,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 09:44:09,1639597467,5/20/2015 09:41:35,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",can precede the diagnosis of,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 09:48:54,1639599021,5/20/2015 09:48:30,false,prodege,1.0,14528761,GBR,V2,Glasgow,90.195.5.143,[SYMPTOM],[SYMPTOM],precede,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 09:57:51,1639601674,5/20/2015 09:57:12,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
723853373,5/20/2015 10:05:55,1639604253,5/20/2015 10:04:10,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[ASSOCIATED_WITH],[ASSOCIATED_WITH],can precede the diagnosis of,N/A,2,41,1,10,55,TWrex-cause,813562-FS1,"• HEMATURIA can precede the diagnosis of BLADDER CANCER by several years according to a retrospective review of 20,571 men and women enrolled in a large prepaid health plan in California ( 53.",HEMATURIA,BLADDER CANCER
